0001543418false--11-302024Q3UnlimitedUnlimited0001543418tmq:AmblerMetalsLlcMember2023-08-310001543418tmq:ContributedSurplusMember2022-12-012023-02-280001543418us-gaap:CommonStockMember2024-06-012024-08-310001543418us-gaap:CommonStockMember2024-03-012024-05-310001543418us-gaap:RetainedEarningsMember2024-08-310001543418tmq:ContributedSurplusUnitsMember2024-08-310001543418tmq:ContributedSurplusStockbasedCompensationMember2024-08-310001543418tmq:ContributedSurplusMember2024-08-310001543418us-gaap:RetainedEarningsMember2024-05-310001543418tmq:ContributedSurplusUnitsMember2024-05-310001543418tmq:ContributedSurplusStockbasedCompensationMember2024-05-310001543418tmq:ContributedSurplusMember2024-05-310001543418us-gaap:RetainedEarningsMember2024-02-290001543418tmq:ContributedSurplusUnitsMember2024-02-290001543418tmq:ContributedSurplusStockbasedCompensationMember2024-02-290001543418tmq:ContributedSurplusMember2024-02-2900015434182024-02-290001543418us-gaap:RetainedEarningsMember2023-11-300001543418tmq:ContributedSurplusUnitsMember2023-11-300001543418tmq:ContributedSurplusStockbasedCompensationMember2023-11-300001543418tmq:ContributedSurplusMember2023-11-300001543418us-gaap:RetainedEarningsMember2023-08-310001543418tmq:ContributedSurplusUnitsMember2023-08-310001543418tmq:ContributedSurplusStockbasedCompensationMember2023-08-310001543418tmq:ContributedSurplusMember2023-08-310001543418us-gaap:RetainedEarningsMember2023-05-310001543418tmq:ContributedSurplusUnitsMember2023-05-310001543418tmq:ContributedSurplusStockbasedCompensationMember2023-05-310001543418tmq:ContributedSurplusMember2023-05-3100015434182023-05-310001543418us-gaap:RetainedEarningsMember2023-02-280001543418tmq:ContributedSurplusUnitsMember2023-02-280001543418tmq:ContributedSurplusStockbasedCompensationMember2023-02-280001543418tmq:ContributedSurplusMember2023-02-2800015434182023-02-280001543418us-gaap:RetainedEarningsMember2022-11-300001543418tmq:ContributedSurplusUnitsMember2022-11-300001543418tmq:ContributedSurplusStockbasedCompensationMember2022-11-300001543418tmq:ContributedSurplusMember2022-11-300001543418us-gaap:CommonStockMember2024-05-310001543418us-gaap:CommonStockMember2024-02-290001543418us-gaap:CommonStockMember2023-08-310001543418us-gaap:CommonStockMember2023-05-310001543418us-gaap:CommonStockMember2023-02-280001543418us-gaap:CommonStockMember2022-11-300001543418us-gaap:EmployeeStockOptionMember2024-08-310001543418us-gaap:EmployeeStockOptionMember2023-11-300001543418tmq:EmployeesConsultantsAndDirectorsMember2023-12-012024-08-310001543418tmq:EmployeesConsultantsAndDirectorsMember2024-06-012024-08-310001543418tmq:EmployeesConsultantsAndDirectorsMember2024-03-012024-05-310001543418us-gaap:EmployeeStockOptionMember2023-12-012024-08-310001543418tmq:RangeTwoMember2024-08-310001543418tmq:RangeSixMember2024-08-310001543418tmq:RangeFourMember2024-08-310001543418us-gaap:RestrictedStockUnitsRSUMember2024-08-310001543418tmq:NumberOfDsusMember2024-08-310001543418us-gaap:RestrictedStockUnitsRSUMember2023-11-300001543418tmq:NumberOfDsusMember2023-11-300001543418us-gaap:RestrictedStockUnitsRSUMember2023-12-012024-08-310001543418srt:ScenarioForecastMember2024-09-012024-11-300001543418tmq:EmployeesConsultantsAndDirectorsMember2023-12-012024-02-290001543418tmq:EmployeesConsultantsAndDirectorsMember2022-12-012023-02-280001543418us-gaap:EmployeeStockOptionMembertmq:DirectorsEmployeesAndServicesProvidersMember2024-06-012024-08-310001543418tmq:EquitySettledAwardsMember2024-06-012024-08-310001543418tmq:ContributedSurplusUnitsMember2024-06-012024-08-310001543418tmq:ContributedSurplusStockbasedCompensationMember2024-06-012024-08-310001543418tmq:ContributedSurplusUnitsMember2024-03-012024-05-310001543418tmq:ContributedSurplusStockbasedCompensationMember2024-03-012024-05-310001543418us-gaap:EmployeeStockOptionMembertmq:DirectorsEmployeesAndServicesProvidersMember2023-12-012024-08-310001543418tmq:NumberOfDsusMember2023-12-012024-08-310001543418tmq:ContributedSurplusUnitsMember2023-12-012024-02-290001543418tmq:ContributedSurplusStockbasedCompensationMember2023-12-012024-02-290001543418us-gaap:EmployeeStockOptionMembertmq:DirectorsEmployeesAndServicesProvidersMember2023-06-012023-08-310001543418tmq:EquitySettledAwardsMember2023-06-012023-08-310001543418tmq:ContributedSurplusUnitsMember2023-06-012023-08-310001543418tmq:ContributedSurplusStockbasedCompensationMember2023-06-012023-08-310001543418tmq:ContributedSurplusStockbasedCompensationMember2023-03-012023-05-310001543418us-gaap:EmployeeStockOptionMembertmq:DirectorsEmployeesAndServicesProvidersMember2022-12-012023-08-310001543418tmq:NumberOfDsusMember2022-12-012023-08-310001543418tmq:ContributedSurplusUnitsMember2022-12-012023-02-280001543418tmq:ContributedSurplusStockbasedCompensationMember2022-12-012023-02-280001543418tmq:AmblerMetalsLlcMember2024-03-012024-05-3100015434182024-07-012024-07-3100015434182024-06-012024-06-300001543418us-gaap:RetainedEarningsMember2024-06-012024-08-310001543418us-gaap:RetainedEarningsMember2024-03-012024-05-3100015434182024-03-012024-05-310001543418us-gaap:RetainedEarningsMember2023-12-012024-02-290001543418us-gaap:RetainedEarningsMember2023-06-012023-08-310001543418us-gaap:RetainedEarningsMember2023-03-012023-05-3100015434182023-03-012023-05-310001543418us-gaap:RetainedEarningsMember2022-12-012023-02-280001543418tmq:South32LimitedMember2020-02-110001543418tmq:CanadianLimitDueToCurrencyRiskMember2023-12-012024-08-310001543418tmq:AmblerMetalsLlcMember2023-11-300001543418tmq:South32LimitedMembertmq:AmblerMetalsLlcMember2024-08-310001543418tmq:South32LimitedMembertmq:AmblerMetalsLlcMember2020-02-110001543418tmq:AmblerMetalsLlcMember2020-02-110001543418tmq:AmblerMetalsLlcMember2024-08-310001543418tmq:NonvestedOptionsMember2024-08-310001543418tmq:AmblerMetalsLlcMember2024-06-012024-08-310001543418tmq:AmblerMetalsLlcMember2023-06-012023-08-310001543418tmq:AmblerMetalsLlcMember2022-12-012023-08-3100015434182022-12-012023-11-3000015434182023-08-3100015434182022-11-3000015434182023-06-012023-08-310001543418us-gaap:SubsequentEventMember2024-09-030001543418us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember2024-08-310001543418us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember2023-11-3000015434182023-12-012024-02-2900015434182022-12-012023-02-280001543418srt:ManagementMemberus-gaap:RestrictedStockUnitsRSUMemberus-gaap:SubsequentEventMember2024-09-032024-09-030001543418srt:DirectorMembertmq:DeferredStockUnitsDsusMemberus-gaap:SubsequentEventMember2024-09-032024-09-030001543418us-gaap:CommonStockMember2023-12-012024-02-290001543418us-gaap:CommonStockMember2022-12-012023-02-280001543418tmq:RangeTwoMember2023-12-012024-08-310001543418tmq:RangeSixMember2023-12-012024-08-310001543418tmq:RangeFourMember2023-12-012024-08-310001543418tmq:AmblerMetalsLlcMember2023-12-012024-08-3100015434182024-05-310001543418tmq:AmblerMetalsLlcMember2020-02-112020-02-110001543418us-gaap:CommonStockMember2023-12-012024-08-310001543418us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember2024-06-012024-08-310001543418us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember2023-12-012024-08-310001543418us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember2023-06-012023-08-310001543418us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember2022-12-012023-08-3100015434182022-12-012023-08-310001543418us-gaap:RelatedPartyMember2023-12-012024-08-310001543418us-gaap:RelatedPartyMember2022-12-012023-08-310001543418us-gaap:CommonStockMember2023-06-012023-08-310001543418tmq:ContributedSurplusMember2023-06-012023-08-310001543418us-gaap:CommonStockMember2023-03-012023-05-310001543418tmq:ContributedSurplusUnitsMember2023-03-012023-05-3100015434182023-11-300001543418us-gaap:LeaseAgreementsMember2024-08-310001543418us-gaap:AccountsPayableAndAccruedLiabilitiesMember2024-08-3100015434182024-08-310001543418tmq:OnePercentChangeInInterestRatesMember2024-08-310001543418tmq:CanadianLimitDueToCurrencyRiskMember2024-08-310001543418us-gaap:CommonStockMember2024-08-310001543418us-gaap:CommonStockMember2023-11-3000015434182024-06-012024-08-3100015434182024-10-0800015434182023-12-012024-08-31xbrli:sharesiso4217:USDxbrli:puretmq:Owneriso4217:CADiso4217:USDxbrli:sharesiso4217:CADxbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Quarterly Period Ended August 31, 2024

OR

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Transition Period from to

Commission File Number: 1-35447

Graphic

TRILOGY METALS INC.

(Exact Name of Registrant as Specified in Its Charter)

British Columbia

98-1006991

(State or Other Jurisdiction of

Incorporation or Organization)

(I.R.S. Employer

Identification No.)

Suite 901, 510 Burrard Street

Vancouver, British Columbia
Canada

V6C 3A8

(Address of Principal Executive Offices)

(Zip Code)

(604) 638-8088

(Registrant’s Telephone Number, Including Area Code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Shares

TMQ

NYSE American

Toronto Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

Yes No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer

Accelerated filer

Non-accelerated filer

Smaller reporting company

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes No

As of October 8, 2024, the registrant had 160,902,814 Common Shares, no par value, outstanding.

PART I - FINANCIAL INFORMATION

Item 1. Financial Statements

Trilogy Metals Inc.

Condensed Interim Consolidated Balance Sheets

(unaudited)

in thousands of US dollars

August 31, 2024

November 30, 2023

  

  

$

  

  

$

  

Assets

  

  

Current assets

  

  

Cash and cash equivalents

25,738

2,590

Accounts receivable

8

33

Deposits and prepaid amounts

352

259

Total current assets

26,098

2,882

Investment in Ambler Metals LLC (note 3)

108,114

135,021

Fixed assets

4

Right of use asset (note 5(a))

164

113

Total assets

134,376

138,020

Liabilities

  

  

Current liabilities

  

  

Accounts payable and accrued liabilities (note 4)

391

432

Current portion of lease liability

37

33

Total current liabilities

428

465

Long-term portion of lease liability

125

Total liabilities

553

465

Shareholders’ equity

  

  

Share capital (note 6) – unlimited common shares authorized, no par value issued – 160,567,514 (2023 – 155,559,334)

190,200

187,886

Contributed surplus

118

118

Contributed surplus – options (note 6(a))

28,741

28,237

Contributed surplus – units (note 6(b))

3,528

3,127

Deficit

(88,764)

(81,813)

Total shareholders' equity

133,823

137,555

Total liabilities and shareholders' equity

134,376

138,020

Subsequent Events (note 8)

(See accompanying notes to the condensed interim consolidated financial statements)

/s/ Tony Giardini, President, CEO and Director

 

/s/ Diana Walters, Director

 

 

 

Approved on behalf of the Board of Directors

 

 

Trilogy Metals Inc.
For the Quarter Ended August 31, 2024

3

Trilogy Metals Inc.

Condensed Interim Consolidated Statements of Loss

and Comprehensive Loss

(unaudited)

in thousands of US dollars, except share and per share amounts

For the three months ended

For the nine months ended

 

August 31, 2024

August 31, 2023

August 31, 2024

August 31, 2023

  

    

$

  

  

$

  

  

$

  

  

$

Expenses

  

 

  

 

  

Amortization

1

2

4

 

6

Exploration expenses

28

22

28

23

Foreign exchange loss (gain)

2

3

3

 

1

General and administrative

293

278

1,027

 

1,014

Investor relations

15

18

46

 

71

Professional fees

138

139

530

 

897

Salaries

158

191

527

 

621

Salaries and directors expense – stock-based compensation

506

526

3,014

 

3,379

Total expenses

1,141

 

1,179

5,179

 

6,012

Other items

  

 

  

  

 

  

Interest and other income

(152)

(37)

(200)

 

(83)

Services agreement income

(22)

(47)

 

Share of loss on equity investment (note 3(b))

624

2,910

2,019

5,998

Loss and comprehensive loss for the period

(1,591)

 

(4,052)

(6,951)

 

(11,927)

Basic loss per common share

(0.01)

(0.03)

(0.04)

(0.08)

Diluted loss per common share

(0.01)

(0.03)

(0.04)

(0.08)

Basic weighted average number of common shares outstanding

160,542,286

155,550,284

159,466,414

151,572,299

Diluted weighted average number of common shares outstanding

160,542,286

155,550,284

159,466,414

151,572,299

(See accompanying notes to the condensed interim consolidated financial statements)

Trilogy Metals Inc.
For the Quarter Ended August 31, 2024

4

Trilogy Metals Inc.

Condensed Interim Consolidated Statements of Changes in Shareholders’ Equity

(unaudited)

in thousands of US dollars, except share amounts

    

Contributed

Contributed

    

Total

 

Contributed

surplus –

surplus –

shareholders’

 

Number of shares

Share capital

surplus

options

units

Deficit

equity

  

outstanding

  

  

$

  

  

$

  

  

$

  

  

$

  

  

$

  

  

$

   

Balance – November 30, 2022

 

146,225,035

182,178

122

27,352

2,638

(66,862)

145,428

Restricted Share Units

 

2,346,366

1,538

(1)

(1,537)

Joint venture contribution

143,505

111

111

Services settled by common shares

 

7,793

4

4

Stock-based compensation

520

1,700

2,220

Loss for the period

 

(5,072)

(5,072)

Balance – February 28, 2023

 

148,722,699

183,831

 

121

 

27,872

 

2,801

 

(71,934)

142,691

Shares issued for private placement, net of share issue cost

5,854,545

3,115

3,115

Restricted Share Units

213,463

121

121

Deferred Share Units conversion

415,056

468

(468)

Services settled by common shares

63,533

35

35

Stock-based compensation

114

257

371

Loss for the period

 

(2,803)

(2,803)

Balance – May 31, 2023

155,269,296

187,570

121

27,986

2,590

(74,737)

143,530

Restricted Share Units

248,092

122

122

Services settled by common shares

40,816

20

20

NovaGold deferred share units conversion

1,130

3

(3)

Stock-based compensation

125

268

393

Loss for the period

 

(4,052)

(4,052)

Balance – August 31, 2023

155,559,334

187,715

118

28,111

2,858

(78,789)

140,013

Balance – November 30, 2023

155,925,990

187,886

118

28,237

3,127

(81,813)

137,555

Restricted Share Units

 

3,633,065

1,804

(1,804)

Joint venture contribution

143,507

112

112

Services settled by common shares

64,368

30

30

Stock-based compensation

 

318

1,681

1,999

Loss for the period

(3,601)

(3,601)

Balance – February 29, 2024

159,766,930

189,832

118

28,555

3,004

(85,414)

136,095

Restricted Share Units

353,347

155

(155)

Services settled by common shares

66,511

30

30

Stock-based compensation

92

417

509

Loss for the period

 

(1,759)

(1,759)

Balance – May 31, 2024

 

160,186,788

190,017

 

118

 

28,647

 

3,266

 

(87,173)

134,875

Restricted Share Units

326,020

153

(153)

Services settled by common shares

54,706

30

30

Stock-based compensation

94

415

509

Loss for the period

 

(1,591)

(1,591)

Balance – August 31, 2024

 

160,567,514

190,200

 

118

 

28,741

 

3,528

 

(88,764)

133,823

(See accompanying notes to the condensed interim consolidated financial statements)

Trilogy Metals Inc.
For the Quarter Ended August 31, 2024

5

Trilogy Metals Inc.

Condensed Interim Consolidated Statements of Cash Flows

(unaudited)

in thousands of US dollars

For the nine months ended

August 31, 2024

August 31, 2023

    

$

  

  

$

  

Cash flows used in operating activities

  

 

  

Loss for the period

(6,951)

 

(11,927)

Adjustments to reconcile net loss to cash flows used in operating activities

 

  

Amortization

4

 

6

Consulting fees settled by common shares

90

86

Office lease accounting

76

(9)

Loss on equity investment in Ambler Metals LLC (note 3(b))

2,019

5,998

Unrealized foreign exchange (gain) loss

 

5

Stock-based compensation

3,014

 

3,379

Net change in non-cash working capital

 

Decrease in accounts receivable

25

 

7

Decrease in deposits and prepaid amounts

(93)

 

(137)

Increase in accounts payable and accrued liabilities

(38)

 

(42)

Total cash flows used in operating activities

(1,854)

 

(2,634)

Cash flows from financing activities

  

 

  

Issuance of common shares, net of share issue cost (note 6(a))

 

3,115

Total cash flows from financing activities

 

3,115

Cash flows from investing activities

  

 

  

Return of capital from Ambler Metals LLC (note 3(c))

25,000

 

Total cash flows from investing activities

25,000

 

Change in cash

23,146

 

481

Effect of exchange rate on cash

2

 

(5)

Cash and cash equivalents – beginning of the period

2,590

 

2,573

Cash and cash equivalents – end of the period

25,738

 

3,049

(See accompanying notes to the condensed interim consolidated financial statements)

Trilogy Metals Inc.
For the Quarter Ended August 31, 2024

6

Table of contents

Trilogy Metals Inc.

Notes to the Condensed Interim Consolidated Financial Statements

1)    Nature of operations

Trilogy Metals Inc. (“Trilogy” or the “Company”) was incorporated in British Columbia, Canada under the Business Corporations Act (British Columbia) on April 27, 2011. The Company is engaged in the exploration and development of mineral properties, through our equity investee (see note 3), with a focus on the Upper Kobuk Mineral Projects (“UKMP”), including the Arctic and Bornite Projects located in Northwest Alaska in the United States of America (“US”). The Company also conducts early-stage exploration through a wholly owned subsidiary, 995 Exploration Inc.  

2)    Summary of significant accounting policies

Basis of presentation

These condensed interim consolidated financial statements have been prepared using accounting principles generally accepted in the United States (“U.S. GAAP”) and include the accounts of Trilogy and its wholly owned subsidiaries, NovaCopper US Inc. (dba “Trilogy Metals US”) and 995 Exploration Inc. All intercompany transactions are eliminated on consolidation. For variable interest entities (“VIEs”) where Trilogy is not the primary beneficiary, we use the equity method of accounting.

All figures are in United States dollars unless otherwise noted. References to CDN$ refer to amounts in Canadian dollars.

These condensed interim consolidated financial statements include all adjustments necessary for the fair statement of the Company’s financial position as of August 31, 2024 and our results of operations and cash flows for the nine-month periods ended August 31, 2024 and August 31, 2023. The results of operations for the nine-month period ended August 31, 2024 are not necessarily indicative of the results to be expected for the fiscal year ending November 30, 2024.

As these condensed interim consolidated financial statements do not contain all of the disclosures required by U.S. GAAP for annual financial statements, these condensed interim consolidated financial statements should be read in conjunction with the annual financial statements and related notes included in our Annual Report on Form 10-K for the fiscal year ended November 30, 2023, filed with the U.S. Securities and Exchange Commission (“SEC”) and Canadian securities regulatory authorities on February 9, 2024.

These condensed interim consolidated financial statements were approved by the Company’s Audit Committee on behalf of the Board of Directors for issue on October 7, 2024.

Use of estimates and measurement uncertainties

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions of future events that affect the reported amount of assets and liabilities and disclosure of contingent liabilities at the date of the financial statements, and the reported amounts of expenditures during the period. Significant estimates include the measurement of income taxes and the valuation of stock-based compensation. Actual results could differ materially from those reported.

Management assesses the possibility of impairment in the carrying value of its equity method investment in Ambler Metals whenever events or circumstances indicate that the carrying amount of the investment may not be recoverable.  Ambler Metals is a non-publicly traded equity investment owning exploration and development projects. Significant judgments are made in assessing the possibility of impairment. The Company assesses whether there has been a potential triggering event for other-than-temporary impairment by assessing the underlying assets of Ambler Metals for recoverability and assessing whether there has been a change in the development plan or strategy for the projects.  If the Company concludes there is sufficient evidence for an other-than-temporary impairment, an assessment of fair value is performed.  If the underlying assets are not recoverable, the Company will record an impairment charge equal to the difference between the carrying amount of the equity investment and its fair value.  This assessment is subjective and requires consideration at each period end.

Trilogy Metals Inc.
For the Quarter Ended August 31, 2024

7

Table of contents

Trilogy Metals Inc.

Notes to the Condensed Interim Consolidated Financial Statements

3)    Investment in Ambler Metals LLC

(a)

Formation of Ambler Metals LLC

On February 11, 2020, the Company completed the formation of a 50/50 joint venture named Ambler Metals LLC (“Ambler Metals”) with South32 Limited (“South32”). As part of the formation of the joint venture, Trilogy contributed all its assets associated with the UKMP, including the Arctic and Bornite Projects, while South32 contributed cash of $145.0 million, resulting in each party’s subsidiaries directly owning a 50% interest in Ambler Metals.

Ambler Metals is a company jointly controlled by Trilogy and South32 through a four-member board, of which two members are appointed by Trilogy based on its 50% equity interest. All significant decisions related to the UKMP require the approval of both companies. We determined that Ambler Metals is a VIE because it is expected to need additional funding from its owners for its significant activities. However, we concluded that we are not the primary beneficiary of Ambler Metals as the power to direct its activities, through its board, is shared under the Ambler Metals LLC limited liability company agreement. As we have significant influence over Ambler Metals through our representation on its board, we use the equity method of accounting for our investment in Ambler Metals. Our maximum exposure to loss in this entity is limited to the carrying amount of our investment in Ambler Metals, which, as of August 31, 2024, totaled $108.1 million (2023 - $136.9 million).

(b)

Carrying value of equity method investment

Trilogy recognized, based on its 50% ownership interest in Ambler Metals, an equity loss equivalent to its pro rata share of Ambler Metals’ comprehensive loss of $1.2 million for the three-month period ending August 31, 2024 (2023 - $5.8 million) and $4.0 million for the nine-month period ending August 31, 2024 (2023 - $12.0 million).  During the nine-month period ending August 31, 2024, Trilogy made a $112,000 equity contribution to Ambler Metals through the issuance of 143,507 common shares of the Company as part of the long-term incentive compensation for Ambler Metals executives. Likewise, South32 made an equivalent equity contribution to Ambler Metals for $112,000 in cash for their 50% share. The carrying value of Trilogy’s 50% investment in Ambler Metals as at August 31, 2024 is summarized on the following table.

    

in thousands of dollars

$

  

November 30, 2023, Investment in Ambler Metals

135,021

Joint venture equity contribution

112

Return of capital

(25,000)

Share of loss on equity investment for the nine-month period ending August 31, 2024

(2,019)

August 31, 2024, Investment in Ambler Metals

108,114

(c)

The following table summarizes Ambler Metals’ Balance Sheet as at August 31, 2024.

    

in thousands of dollars

August 31, 2024

November 30, 2023

    

$

  

  

$

  

Total assets

41,888

97,180

Cash and cash equivalents

9,848

63,829

Mineral properties

30,899

30,899

Total liabilities

(1,455)

(2,931)

Accounts payable and accrued liabilities

(1,209)

(2,500)

Members' equity (total assets less total liabilities)

40,433

94,249

Trilogy Metals Inc.
For the Quarter Ended August 31, 2024

8

Table of contents

Trilogy Metals Inc.

Notes to the Condensed Interim Consolidated Financial Statements

Ambler Metals’ cash and cash equivalents are held at one bank of which the majority is uninsured.  During the second and third quarters, Ambler Metals returned $50 million of excess cash to the members.  

(d) The following table summarizes Ambler Metals' loss for the three-month and nine-month periods ended August 31, 2024 and August 31, 2023.

in thousands of dollars

Three months ended

Nine months ended

August 31, 2024

August 31, 2023

August 31, 2024

August 31, 2023

  

$

  

  

$

  

  

$

  

  

$

  

Depreciation

38

38

113

113

Corporate salaries and wages

49

478

411

1,417

General and administrative

93

43

343

389

Mineral property expense

1,024

5,210

3,348

10,002

Professional fees

325

181

755

397

Foreign exchange loss

(6)

2

(3)

Interest and other income

(281)

(125)

(933)

(319)

Comprehensive loss

1,248

5,819

4,039

11,996

(e) Related party transactions

During the nine-month period ended August 31, 2024, the Company charged $47,000 (2023 - $Nil) related to human resources and accounting services in connection with a service agreement between the Company and Ambler Metals. In addition, the Company received payments of $64,000 (2023 - $Nil) related to operating expenses paid on behalf of Ambler Metals pursuant to the service agreement.

4)    Accounts payable and accrued liabilities

in thousands of dollars

August 31, 2024

November 30, 2023

  

$

  

  

$

  

Trade accounts payable

51

146

Accrued liabilities

 

88

 

54

Accrued salaries and vacation

 

252

 

232

Accounts payable and accrued liabilities

 

391

 

432

Subsequent to the end of the third quarter, on September 3, 2024, approximately $153,000 of accrued salaries was settled through the issuance of common shares of the Company.

Trilogy Metals Inc.
For the Quarter Ended August 31, 2024

9

Table of contents

Trilogy Metals Inc.

Notes to the Condensed Interim Consolidated Financial Statements

5)    Leases

(a)Right-of-use asset

in thousands of dollars

  

$

  

Balance as at November 30, 2023

113

Net amortization for lease ended June 30, 2024

(113)

ROU assets recognized for lease commenced July 1, 2024

170

Net amortization for lease commenced July 1, 2024

(6)

Balance as at August 31, 2024

164

The Company’s previous office lease ended on June 30, 2024.  The Company entered into a new office lease commencing on July 1, 2024, with a 4-year term ending in June 2028, and with no renewal option.  During the quarter ended August 31, 2024, the Company recognized a ROU asset of $170,000 for the new office lease.

(b)Lease liabilities

The Company’s lease arrangement consists of an operating lease for our office space ending in June 2028. There are no extension options.

Total lease expense recorded within general and administrative expenses was comprised of the following components:

    

in thousands of dollars

Nine months ended

Nine months ended

August 31, 2024

August 31, 2023

$

  

  

$

  

Operating lease costs

122

140

Variable lease costs

103

103

Total lease expense

225

243

Variable lease costs consist primarily of the Company’s portion of operating costs associated with the office space lease as the Company elected to apply the practical expedient not to separate lease and non-lease components.

As at August 31, 2024, the weighted-average remaining lease term is 3.8 years and the weighted-average discount rate is 9%. Significant judgment was used in the determination of the incremental borrowing rate which included estimating the Company’s credit rating.

Supplemental cash and non-cash information relating to our leases during the nine-month period ending August 31, 2024 are as follows:

Cash paid for amounts included in the measurement of lease liabilities was $45,561, of which $33,159 related to the office lease that expired on June 30, 2024 and $12,402 related to the new office lease that commenced on July 1, 2024.

Trilogy Metals Inc.
For the Quarter Ended August 31, 2024

10

Table of contents

Trilogy Metals Inc.

Notes to the Condensed Interim Consolidated Financial Statements

Future minimum payments relating to the lease recognized in our balance sheet as of August 31, 2024 are as follows:

    

in thousands of dollars

August 31, 2024

 

Fiscal year

$

  

2024

 

13

2025

 

50

2026

 

51

2027

 

51

2028

 

30

Total undiscounted lease payments

 

195

Effect of discounting

 

(33)

Present value of lease payments recognized as lease liability

 

162

6)    Share capital

Authorized:

unlimited common shares, no par value

in thousands of dollars, except share amounts

Number of shares

Ascribed value

    

  

  

$

  

November 30, 2023

 

155,925,990

187,886

Restricted Share Units

4,312,432

2,112

Services settled by common shares

185,585

90

Joint venture equity contribution (note 3(a))

143,507

112

August 31, 2024, issued and outstanding

160,567,514

190,200

(a)

Stock options

During the three-month period ended February 29, 2024, the Company granted 2,775,000 stock options (2023 - 3,230,000 stock options) at an exercise price of CDN$0.59 (2023 - CDN$0.78) to employees, consultants and directors exercisable for a period of five years with various vesting terms from immediate vesting to vesting over a two-year period. The fair value attributable to each of these option grants was CDN$0.27 (2023 - CDN$0.37).  No grants were made during the three-month periods ended May 31, 2024 or August 31, 2024.

For the three-month period ended August 31, 2024, Trilogy recognized a stock-based compensation charge of $0.1 million (2023 - $0.1 million) for options granted to directors, employees and service providers, net of estimated forfeitures. For the nine-month period ended August 31, 2024, Trilogy recognized a stock-based compensation charge of $0.5 million (2023 - $0.8 million) for options granted to directors, employees and service providers, net of estimated forfeitures.

The fair value of the stock options recognized in the period has been estimated using the Black-Scholes option pricing model.

Trilogy Metals Inc.
For the Quarter Ended August 31, 2024

11

Table of contents

Trilogy Metals Inc.

Notes to the Condensed Interim Consolidated Financial Statements

Assumptions used in the pricing model for the nine-month period ended August 31, 2024 are as provided below.

    

August 31, 2024

Risk-free interest rates

 

3.84%

Exercise price

 

CDN$0.59

Expected life

 

3 years

Expected volatility

 

65.5%

Expected dividends

 

Nil

As at August 31, 2024, there were 2,533,339 non-vested options outstanding with a weighted average exercise price of CDN$0.66. The value of non-vested stock option expense not yet recognized was $0.2 million of which approximately $0.1 million will be recognized during the quarter ending November 30, 2024 and the remainder throughout the next fiscal year.

A summary of the Company’s stock options outstanding and changes during the nine-month period ended August 31, 2024 is as follows:

August 31, 2024

Weighted average

exercise price

    

Number of options

  

  

CDN$

  

Balance – beginning of the period

 

12,649,400

2.15

Granted

 

2,775,000

0.59

Expired

 

(1,107,500)

2.96

Balance – end of the period

 

14,316,900

1.78

There were no stock options exercised during the nine-month period ended August 31, 2024.

The following table summarizes information about the stock options outstanding at August 31, 2024.

Outstanding

Exercisable

Unvested

 

Weighted

Weighted

 

Number of

Weighted

average

Number of

average

Number of

 

outstanding

average years

exercise price

exercisable

exercise price

unvested

Range of exercise price - CDN

  

options

  

  

to expiry

  

  

CDN$

  

  

options

  

  

CDN$

  

  

options  

  

$0.59 to $1.00

 

5,955,000

3.73

0.69

3,421,661

0.72

2,533,339

$2.01 to $3.00

 

7,016,900

1.21

2.47

7,016,900

2.47

$3.01 to $3.02

1,345,000

0.32

3.02

1,345,000

3.02

14,316,900

2.18

1.78

11,783,561

2.03

2,533,339

The aggregate intrinsic value of vested stock options (the market value less the exercise price) at August 31, 2024 was $Nil (2023 - $Nil) and the aggregate intrinsic value of exercised options for the nine-month period ending August 31, 2024 was $Nil (2023 - $Nil).

(b)

Restricted Share Units and Deferred Share Units

The Company has a Restricted Share Unit Plan (“RSU Plan”) to provide long-term incentives to employees and consultants, a Non-Executive Director Deferred Share Unit Plan (“DSU Plan”), and a Non-Executive Directors Fixed Deferred Share Unit Plan (“Fixed DSU Plan”) to offset cash payments for fees to directors.  Awards under the RSU Plan, DSU Plan and Fixed DSU Plan will be settled in common shares of the Company with each restricted share unit (“RSU”) and deferred share unit (“DSU”) entitling the holder to receive one common share of the Company.  All units are accounted for as equity-settled awards.

Trilogy Metals Inc.
For the Quarter Ended August 31, 2024

12

Table of contents

Trilogy Metals Inc.

Notes to the Condensed Interim Consolidated Financial Statements

A summary of the Company’s unit plans and changes during the nine-month period ending August 31, 2024 is as follows:

    

Number of RSUs

  

  

Number of DSUs

  

  

Number of Fixed DSUs

  

Balance – beginning of the period

1,610,638

 

2,428,701

Granted

 

5,705,718

551,676

Vested/Converted

 

(4,498,017)

Balance – end of the period

 

2,818,339

 

2,980,377

For the three-month period ending August 31, 2024, Trilogy recognized a combined RSU and DSU stock-based compensation charge of $0.2 million (2023 - $0.2 million), net of estimated forfeitures. For the nine-month period ending August 31, 2024, Trilogy recognized a combined RSU and DSU stock-based compensation charge of $1.8 million (2023 - $2.0 million), net of estimated forfeitures.

7)    Financial instruments

The Company is exposed to a variety of risks arising from financial instruments. These risks and management’s objectives, policies and procedures for managing these risks are disclosed as follows.

The Company’s financial instruments consist of cash and cash equivalents, accounts receivable, deposits, and accounts payable and accrued liabilities. The fair value of the Company’s financial instruments approximates their carrying value due to the short-term nature of their maturity. The Company’s financial instruments initially measured at fair value and then held at amortized cost include cash and cash equivalents, accounts receivable, deposits, and accounts payable and accrued liabilities.

Financial risk management

The Company’s activities expose it to certain financial risks, including currency risk, credit risk, liquidity risk, interest risk and price risk.

(a)

Currency risk

Currency risk is the risk of a fluctuation in financial asset and liability settlement amounts due to a change in foreign exchange rates. The Company operates in the United States and Canada. The Company’s exposure to currency risk at August 31, 2024 is limited to the Canadian dollar balances consisting of cash of approximately CDN$11,000, accounts receivable of approximately CDN$11,000 and accounts payable of approximately CDN$34,000. Based on a 10% change in the US-Canadian exchange rate, assuming all other variables remain constant, the Company’s net loss would change by approximately $1,000.

(b)

Credit risk

Credit risk is the risk of an unexpected loss if a customer or third party to a financial instrument fails to meet its contractual obligations. The Company holds cash with a Canadian chartered financial institution of which the majority is uninsured as at August 31, 2024. The Company’s only significant exposure to credit risk is equal to the balance of cash as recorded in the financial statements.

(c)

Liquidity risk

Liquidity risk is the risk that the Company will encounter difficulties raising funds to meet its financial obligations as they fall due. The Company is in the exploration stage and does not have cash inflows from operations; therefore, the Company manages liquidity risk through the management of its capital structure and financial leverage.

Trilogy Metals Inc.
For the Quarter Ended August 31, 2024

13

Table of contents

Trilogy Metals Inc.

Notes to the Condensed Interim Consolidated Financial Statements

Contractually obligated undiscounted cash flow requirements as at August 31, 2024 are as follows:

in thousands of dollars

  

  

Total

  

  

< 1 Year

  

  

1–2 Years

  

  

2–5 Years

  

  

Thereafter

  

$

$

$

$

$

Accounts payable and accrued liabilities

 

391

 

391

 

Office lease

 

195

50

102

43

 

 

586

 

441

 

102

43

Included in accounts payable and accrued liabilities approximately $153,000 is for accrued salaries that were settled, subsequent to the end of the third quarter, on September 3, 2024, by the way of a grant of RSUs which was paid out through the issuance of common shares of the Company (note 8).

(d)

Interest rate risk

Interest rate risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in market interest rates. The Company is exposed to interest rate risk with respect to interest earned on cash. Based on balances as at August 31, 2024 of approximately $25 million, a 1% change in interest rates would result in a change of approximately $250,000 over a one year period, assuming all other variables remain constant.

As we are currently in the exploration phase, none of our financial instruments are exposed to commodity price risk; however, our ability to obtain long-term financing and its economic viability could be affected by commodity price volatility.

8) Subsequent events

On September 3, 2024, pursuant to previous elections, the Board of Directors were granted 153,035 DSUs in settlement of approximately $78,250 of director fees and senior management were granted 298,263 RSUs in lieu of cash salaries of approximately $153,000, all vesting immediately. The grants were in support of continued cash preservation efforts.

Trilogy Metals Inc.
For the Quarter Ended August 31, 2024

14

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Trilogy Metals Inc.

Management’s Discussion & Analysis

For the Quarter Ended August 31, 2024

(expressed in US dollars)

Cautionary notes

Forward-looking statements

This Management’s Discussion and Analysis (“MD&A”) contains “forward-looking information” and “forward-looking statements” within the meaning of Section 27A of the U.S. Securities Act of 1933, as amended, Section 21E of the U.S. Securities Exchange Act of 1934, as amended (the “Exchange Act”), and other applicable securities laws. These forward-looking statements may include statements regarding the Company’s work programs and budgets; perceived merit of properties, exploration results and budgets, the impact of the Bureau of Land Management’s (“BLM”) suspension of permits on the right-of-way with the Alaska Industrial Development and Export Authority (“AIDEA”) relating to the Ambler Road Project, the Company and Ambler Metals’ funding requirements, the Company’s cash preservation strategies, the Company’s future funding of Ambler Metals, mineral reserves and resource estimates, work programs, capital expenditures, operating costs, cash flow estimates, production estimates and similar statements relating to the economic viability of a project, timelines, strategic plans, statements regarding Ambler Metals’ plans and expectations relating to its Upper Kobuk Mineral Projects (the “UKMP”, as defined below), sufficiency of the Ambler Metals’ cash to fund the UKMP, impact of COVID-19 on the Company’s operations, market prices for precious and base metals, statements regarding the Ambler Access Project (also known as the Ambler Mining District Industrial Access Project), or other statements that are not statements of fact. These statements relate to analyses and other information that are based on forecasts of future results, estimates of amounts not yet determinable and assumptions of management. Statements concerning mineral resource estimates may also be deemed to constitute “forward-looking statements” to the extent that they involve estimates of the mineralization that will be encountered if the property is developed.

Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions or future events or performance (often, but not always, identified by words or phrases such as “expects”, “is expected”, “anticipates”, “believes”, “plans”, “projects”, “estimates”, “assumes”, “intends”, “strategy”, “goals”, “objectives”, “potential”, “possible” or variations thereof or stating that certain actions, events, conditions or results “may”, “could”, “would”, “should”, “might” or “will” be taken, occur or be achieved, or the negative of any of these terms and similar expressions) are not statements of historical fact and may be forward-looking statements.

Forward-looking statements are based on the beliefs, expectations and opinions of management on the date the statements are made, as well as on a number of material assumptions, which could prove to be significantly incorrect, including about:

our ability to achieve production at the Upper Kobuk Mineral Projects;
the accuracy of our mineral resource and reserve estimates;
the results, costs and timing of future exploration drilling and engineering;
timing and receipt of approvals, consents and permits under applicable legislation;
the adequacy of our financial resources;

Trilogy Metals Inc.
For the Quarter Ended August 31, 2024

15

the receipt of third party contractual, regulatory and governmental approvals for the exploration, development, construction and production of our properties and any litigation or challenges to such approvals;
our expected ability to develop adequate infrastructure and that the cost of doing so will be reasonable;
continued good relationships with South32, our joint venture partner, as well as local communities and other stakeholders;
there being no significant disruptions affecting operations, whether relating to labor, supply, power damage to equipment or other matter;
expected trends and specific assumptions regarding metal prices and currency exchange rates; and
prices for and availability of fuel, electricity, parts and equipment and other key supplies remaining consistent with current levels.

We have also assumed that no significant events will occur outside of our normal course of business. Although we have attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. We believe that the assumptions inherent in the forward-looking statements are reasonable as of the date of this MD&A. However, forward-looking statements are not guarantees of future performance and, accordingly, undue reliance should not be put on such statements due to the inherent uncertainty therein.

Forward-looking statements are subject to a variety of known and unknown risks, uncertainties and other factors that could cause actual events or results to differ from those reflected in the forward-looking statements, including, without limitation:

risks related to inability to define proven and probable reserves;
risks related to our ability to finance the development of our mineral properties through external financing, strategic alliances, the sale of property interests or otherwise;
uncertainty as to whether there will ever be production at the Company’s mineral exploration and development properties;
risks related to our ability to commence production and generate material revenues or obtain adequate financing for our planned exploration and development activities;
risks related to lack of infrastructure including but not limited to the risk whether or not the Ambler Mining District Industrial Access Project, or AMDIAP, will receive the requisite permits and, if it does, whether the Alaska Industrial Development and Export Authority will build the AMDIAP;
risks related to the suspension by the BLM of the right-of-way permits with AIDEA relating to the AMDIAP to permit the Department of the Interior to carry out additional work on the environmental impact statement, and associated delays relating to such suspension;
risks related to inclement weather which may delay or hinder exploration activities at our mineral properties;
risks related to our dependence on a third party for the development of our projects;
none of the Company’s mineral properties are in production or are under development;

Trilogy Metals Inc.
For the Quarter Ended August 31, 2024

16

commodity price fluctuations;
uncertainty related to title to our mineral properties;
our history of losses and expectation of future losses;
risks related to increases in demand for equipment, skilled labor and services needed for exploration and development of mineral properties, and related cost increases;
risks related to increases in costs of fuel and other required supplies and concerns relating to supply chain and the ability to obtain needed supplies at a reasonable cost, or at all;
risks related to global economic instability, including global supply chain issues, inflation and fuel and energy costs may affect the Company’s business;
uncertainties relating to the assumptions underlying our resource estimates, such as metal pricing, metallurgy, mineability, marketability and operating and capital costs;
uncertainty related to inferred mineral resources;
mining and development risks, including risks related to infrastructure, accidents, equipment breakdowns, labor disputes or other unanticipated difficulties with or interruptions in development, construction or production;
risks and uncertainties relating to the interpretation of drill results, the geology, grade and continuity of our mineral deposits;
risks related to governmental regulation and permits, including environmental regulation, including the risk that more stringent requirements or standards may be adopted or applied due to circumstances unrelated to the Company and outside of our control;
the risk that permits and governmental approvals necessary to develop and operate mines at our mineral properties will not be available on a timely basis or at all;
risks related to the need for reclamation activities on our properties and uncertainty of cost estimates related thereto;
risks related to the acquisition and integration of operations or projects;
our need to attract and retain qualified management and technical personnel;
risks related to conflicts of interests of some of our directors and officers;
risks related to potential future litigation;
risks related to market events and general economic conditions;
risks related to future sales or issuances of equity securities decreasing the value of existing Trilogy common shares, diluting voting power and reducing future earnings per share;
risks related to the voting power of our major shareholders and the impact that a sale by such shareholders may have on our share price;
uncertainty as to the volatility in the price of the Company’s common shares;

Trilogy Metals Inc.
For the Quarter Ended August 31, 2024

17

the Company’s expectation of not paying cash dividends;
adverse federal income tax consequences for U.S. shareholders should the Company be a passive foreign investment company;
risks related to global climate change;
risks related to adverse publicity from non-governmental organizations;
uncertainty as to our ability to maintain the adequacy of internal control over financial reporting as per the requirements of Section 404 of the Sarbanes-Oxley Act; and
increased regulatory compliance costs, associated with rules and regulations promulgated by the United States Securities and Exchange Commission, Canadian Securities Administrators, the NYSE American Stock Exchange, the Toronto Stock Exchange, and the Financial Accounting Standards Boards, and more specifically, our efforts to comply with the Dodd-Frank Wall Street Reform and Consumer Protection Act.

This list is not exhaustive of the factors that may affect any of the Company’s forward-looking statements. Forward-looking statements are statements about the future and are inherently uncertain, and actual achievements of the Company or other future events or conditions may differ materially from those reflected in the forward-looking statements due to a variety of risks, uncertainties and other factors, including, without limitation, those referred to in Trilogy’s Form 10-K for the fiscal year ended November 30, 2023, filed with the Canadian securities regulatory authorities and the SEC on February 9, 2024, and other information released by Trilogy and filed with the appropriate regulatory agencies.

The Company’s forward-looking statements are based on the beliefs, expectations and opinions of management on the date the statements are made, and the Company does not assume any obligation to update forward-looking statements if circumstances or management’s beliefs, expectations or opinions should change, except as required by law. For the reasons set forth above, investors should not place undue reliance on forward-looking statements.

General

This Management’s Discussion and Analysis (“MD&A”) of Trilogy Metals Inc. (“Trilogy”, “Trilogy Metals”, “the Company” or “we”) is dated October 8, 2024 and provides an analysis of our unaudited condensed interim financial results for the quarter ended August 31, 2024 compared to the quarter ended August 31, 2023.

The following information should be read in conjunction with our August 31, 2024 unaudited condensed interim consolidated financial statements and related notes which were prepared in accordance with United States generally accepted accounting principles (“U.S. GAAP”). The MD&A should also be read in conjunction with our audited consolidated financial statements and related notes for the year ended November 30, 2023. A summary of the U.S. GAAP accounting policies is outlined in note 2 of the audited consolidated financial statements. All amounts are in United States dollars unless otherwise stated. References to “Canadian dollars” and “CDN$” are to the currency of Canada and references to “U.S. dollars”, “$” or “US$” are to the currency of the United States.

Richard Gosse, P.Geo., Vice President, Exploration of the Company, is a Qualified Person under National Instrument 43-101 - Standards of Disclosure for Mineral Projects (“NI 43-101”), and has approved the scientific and technical information in this MD&A.

Trilogy’s shares are listed on the Toronto Stock Exchange (“TSX”) and the NYSE American Stock Exchange (“NYSE American”) under the symbol “TMQ”. Additional information related to Trilogy, including our annual report on Form 10-K for the fiscal year ended November 30, 2023, is available on SEDAR+ at www.sedarplus.com and on EDGAR at www.sec.gov.

Trilogy Metals Inc.
For the Quarter Ended August 31, 2024

18

Description of business

We are a base metals exploration company focused on the exploration and development of mineral properties, through our equity investee, in the Ambler mining district located in Alaska, U.S.A. We conduct our operations through a wholly owned subsidiary, NovaCopper US Inc. which is doing business as Trilogy Metals US (“Trilogy Metals US”). Our Upper Kobuk Mineral Projects (“UKMP” or “UKMP Projects”) were contributed into a 50/50 joint venture named Ambler Metals LLC (“Ambler Metals”) between Trilogy and South32 Limited (“South32”) on February 11, 2020 (see below). The projects contributed to Ambler Metals consist of: i) the Ambler lands which host the Arctic copper-zinc-lead-gold-silver project (the “Arctic Project”); and ii) the Bornite lands being explored under a collaborative long-term agreement with NANA Regional Corporation, Inc. (“NANA”), a regional Alaska Native Corporation, which hosts the Bornite carbonate-hosted copper project (the “Bornite Project”) and related assets. The Company may also conduct early-stage exploration through a wholly owned subsidiary, 995 Exploration Inc.

Corporate and project activities

The Company has a 2024 fiscal year cash budget totaling $2.8 million.  For the nine-month period ended August 31, 2024, we used $1.9 million in operating activities mainly for personnel costs, professional fees, regulatory and office expenses compared with budgeted cash expenditures totaling $2.1 million.  

Ambler Metals LLC

The board of Ambler Metals approved a 2024 fiscal year budget totaling $5.5 million to support external and community affairs, to maintain the State of Alaska mineral claims in good standing, and for the maintenance of physical assets.  During the nine-month period ended August 31, 2024, Ambler Metals expended $3.5 million on salaries and wages, professional fees, engineering, project support costs and mineral property expenses, excluding the Ambler Access Project (the “AAP”) costs, compared with the budget of $4.5 million.

The board of Ambler Metals also approved a 2024 fiscal year budget totaling $2.5 million to support the AAP.  During the nine-month period ended August 31, 2024, Ambler Metals funded $1.4 million to the Alaska Industrial Development and Export Authority (“AIDEA”) in support of the AAP compared with the budget of $1.9 million.

During the third quarter of 2024, we received additional cash from Ambler Metals.  In total, Ambler Metals returned $50 million to Trilogy and South32 as at August 31, 2024.

Ambler Mining District Industrial Access Project (“AMDIAP” or “Ambler Access Project”)  

On April 22, 2024, the Company announced that the United States Bureau of Land Management (“BLM”) had filed the Final Supplemental Environmental Impact Statement (“SEIS”) for the AAP on its website.  The Final SEIS identifies “No Action” as the BLM’s preferred alternative.  The proponent for the AAP is AIDEA which is a public corporation of the State of Alaska.  AIDEA’s purpose is to promote, develop, and advance general prosperity and economic welfare of the people of Alaska.  AIDEA strongly objected to both the process used by the BLM to reach a “No Build” decision and the effect of the decision which AIDEA believes illegally blocks access to statehood lands, minerals, and federally patented mining claims.  On May 8, 2024, NANA announced its withdrawal from further involvement with the AAP and stated its intentions to not renew the surface access permit with AIDEA upon the permit’s expiry this year.

On June 28, 2024, the BLM issued the Record of Decision confirming their selection of the No Action alternative and thus denied AIDEA’s application for a right-of-way grant (“ROW Grant”) across BLM-managed lands which terminated the BLM ROW Grant issued to AIDEA on January 5, 2021.

Trilogy Metals Inc.
For the Quarter Ended August 31, 2024

19

Summary of results

in thousands of US dollars, except per share amounts

Three months ended

Nine months ended

August 31, 2024

August 31, 2023

August 31, 2024

August 31, 2023

Selected expenses

  

$

  

$

  

$

  

$

  

General and administrative

293

278

1,027

1,014

Investor relations

15

18

46

71

Professional fees

138

139

530

897

Salaries

158

191

527

621

Salaries and directors expense – stock-based compensation

506

526

3,014

3,379

Share of loss on equity investment

624

2,910

2,019

5,998

Comprehensive loss for the period

(1,591)

(4,052)

(6,951)

(11,927)

Basic and diluted loss per common share

(0.01)

(0.03)

(0.04)

(0.08)

For the three-month period ended August 31, 2024, we reported a net loss of $1.6 million compared to a net loss of $4.1 million for the three-month period ended August 31, 2023. The decrease in comprehensive loss in the third quarter of 2024 compared to the same quarter in 2023 is primarily due to the decrease in our share of loss of Ambler Metals.  The decrease of our share of losses of Ambler Metals is mainly due to the decrease in corporate wages and in mineral property expenses partially offset from the increase in professional fees.  The primary drivers in decrease in mineral property expenses over the comparative quarter in the prior year were from a reduction in activities both at the project level and at the AAP.

For the nine-month period ended August 31, 2024, we reported a net loss of $7.0 million compared to a net loss of $11.9 million for the nine-month period ended August 31, 2023. The decrease for the nine-month period ended August 31, 2024, when compared to the same period in 2023, is primarily due to the decrease in our share of losses of Ambler Metals, professional fees and stock-based compensation and salaries. The decrease of our share of losses of Ambler Metals is mainly due to the decrease in corporate wages due to a reduction in staffing and a reduction in mineral property expenses due to a reduction in project activities which was partially offset by the increase in professional fees related to part-time contractors engaged to assist with management of Ambler Metals, along with consultants engaged in government and external affairs.

Liquidity and capital resources

We expended $1.9 million on operating activities during the nine-month period ending August 31, 2024 with the majority of cash spent on professional fees and American and Canadian securities commission fees related to our annual regulatory filings, annual fees paid to the Toronto Stock Exchange and the NYSE American Exchange and corporate salaries.  

As at August 31, 2024, we had cash and cash equivalents and working capital of $25.7 million. During the nine months ended August 31, 2024, Trilogy received a total of $25.0 million from Ambler Metals as a return of excess cash to the owners.  Although the Company has a strong cash position, management continues with cash preservation strategies to reduce cash expenditures where feasible, including but not limited to reductions in marketing and investor conferences and office expenses. In addition, the Company’s board of directors continue to take all of their fees in deferred share units in an effort to preserve cash.  The Company’s senior management team is also continuing to take a portion of their base salaries and all of their short and long term compensation in shares of the Company to preserve cash.

All project related costs are funded by Ambler Metals. Ambler Metals had $9.8 million in cash and cash equivalents and $8.7 million in working capital as at August 31, 2024. There are sufficient funds at Ambler Metals to fund this fiscal year’s budget for the UKMP and the AAP.

Trilogy Metals Inc.
For the Quarter Ended August 31, 2024

20

Off-balance sheet arrangements

We have no material off-balance sheet arrangements.

Outstanding share data

As at October 8, 2024, we had 160,902,814 common shares issued and outstanding. As at October 8, 2024, we had 14,316,900 stock options outstanding with a weighted-average exercise price of CDN$1.78, 3,133,412 Deferred Share Units (“DSUs”), and 2,818,339 Restricted Share Units (“RSUs”) outstanding. As at October 8, 2024 we hold 5,144 NovaGold Resources Inc. (“NovaGold”) DSUs for which the NovaGold director is entitled to receive one common share of Trilogy for every six NovaGold shares to be received upon their retirement from the NovaGold board.  A total of 859 common shares will be issued upon redemption of the NovaGold DSUs. Upon the exercise of all the foregoing convertible securities, the Company would be required to issue an aggregate of 20,268,651 common shares.

New accounting pronouncements

There are no new accounting pronouncements affecting the Company.

Critical accounting estimates

The most critical accounting estimates upon which our financial status depends are those requiring estimates of the recoverability of our equity method investment in Ambler Metals, income taxes and valuation of stock‐based compensation.

Impairment of Investment in Ambler Metals LLC

Management assesses the possibility of impairment in the carrying value of its equity method investment in Ambler Metals whenever events or circumstances indicate that the carrying amount of the investment may not be recoverable. Ambler Metals is a non-publicly traded equity investment owning exploration and development projects.  Significant judgments are made in assessing the possibility of impairment. The Company assesses whether there has been a potential triggering event for other-than-temporary impairment by assessing the underlying assets of Ambler Metals for recoverability and assessing whether there has been a change in the development plan or strategy for the projects.  If the Company concludes there is sufficient evidence for an other-than-temporary impairment, an assessment of fair value is performed.  If the underlying assets are not recoverable, the Company will record an impairment charge equal to the difference between the carrying amount of the equity investment and its fair value.  This assessment is subjective and require consideration at each period end.

Income taxes

We must make estimates and judgments in determining the provision for income tax expense, deferred tax assets and liabilities, and liabilities for unrecognized tax benefits including interest and penalties. We are subject to income tax law in the United States and Canada. The evaluation of tax liabilities involving uncertainties in the application of complex tax regulation is based on factors such as changes in facts or circumstances, changes in tax law, new audit activity, and effectively settled issues. The evaluation of an uncertain tax position requires significant judgment, and a change in such recognition would result in an additional charge to the income tax expense and liability.

Trilogy Metals Inc.
For the Quarter Ended August 31, 2024

21

Stock-based compensation

Compensation expense for options granted to employees, directors and certain service providers is determined based on estimated fair values of the options at the time of grant using the Black-Scholes option pricing model, which takes into account, as of the grant date, the fair market value of the shares, expected volatility, expected life, expected forfeiture rate, expected dividend yield and the risk-free interest rate over the expected life of the option. The use of the Black-Scholes option pricing model requires input estimation of the expected life of the option, volatility, and forfeiture rate which can have a significant impact on the valuation model, and resulting expense recorded.

Additional information

Additional information regarding the Company, including our annual report on Form 10-K for the fiscal year ended November 30, 2023, is available on SEDAR+ at www.sedarplus.com and EDGAR at www.sec.gov and on our website at www.trilogymetals.com. Information contained on our website is not incorporated by reference.

Item 3. Quantitative and Qualitative Disclosures about Market Risk

Not applicable.

Item 4. Controls and Procedures

Disclosure controls and procedures

Disclosure controls and procedures are designed to ensure that information required to be disclosed in reports filed or submitted by the Company under U.S. and Canadian securities legislation is recorded, processed, summarized and reported within the time periods specified in those rules, including providing reasonable assurance that material information is gathered and reported to senior management, including the Chief Executive Officer (“CEO”) and Chief Financial Officer (“CFO”), as appropriate, to permit timely decisions regarding public disclosure. Management, including the CEO and CFO, has evaluated the effectiveness of the design and operation of the Company’s disclosure controls and procedures, as defined in Rule 13a-15(e) and 15d-15(e) of the U.S. Securities Exchange Act of 1934, as amended (the “Exchange Act”) and the rules of Canadian Securities Administration, as of August 31, 2024. Based on this evaluation, the CEO and CFO have concluded that the Company’s disclosure controls and procedures were effective.

Internal control over financial reporting

Management is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rule 13a-15(f) and 15d-15(f) of the Exchange Act and National Instrument 52-109 Certification of Disclosure in Issuer’s Annual and Interim filings. Any system of internal control over financial reporting, no matter how well designed, has inherent limitations. Therefore, even those systems determined to be effective can provide only reasonable assurance with respect to financial statement preparation and presentation.

Changes in internal control over financial reporting

There have been no changes in our internal controls over financial reporting during the fiscal quarter ended August 31, 2024 which have materially affected, or are reasonably likely to materially affect, our internal controls over financial reporting. We continue to evaluate our internal control over financial reporting on an ongoing basis to identify improvements.

Trilogy Metals Inc.
For the Quarter Ended August 31, 2024

22

PART II - OTHER INFORMATION

Item 1. Legal Proceedings

From time to time, we are a party to routine litigation and proceedings that are considered part of the ordinary course of its business. We are not aware of any material current, pending, or threatened litigation.

Item 1A. Risk Factors

Trilogy and its future business, operations and financial condition are subject to various risks and uncertainties due to the nature of its business and the present stage of exploration of its mineral properties. Certain of these risks and uncertainties are under the heading “Risk Factors” under Trilogy’s Form 10-K for the fiscal year ended November 30, 2023 (“Form 10-K”) which is available on SEDAR+ at www.sedarplus.com and EDGAR at www.sec.gov and on our website at www.trilogymetals.com.  There have been no material changes to the risk factors set forth in Trilogy’s Form 10-K.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

None.

Item 3. Defaults Upon Senior Securities

None.

Item 4. Mine Safety Disclosures

These disclosures are not applicable to us.

Item 5. Other Information

a)None.
b)None.
c)During the quarterly period ended August 31, 2024, no director or officer adopted or terminated any Rule 10b5-1 trading arrangement, and/or any non-Rule 10b5-1 trading arrangement (as such terms are defined pursuant to Item 408(a) of Regulation S-K).

Item 6. Exhibits

Exhibit No.

    

Description

3.1

Certificate of Incorporation, dated April 27, 2011 (incorporated by reference Exhibit 99.2 to the Registration Statement on Form 40-F as filed on March 1, 2012, File No. 001-35447)

3.2

Articles of Trilogy Metals Inc., effective April 27, 2011, as altered March 20, 2011 (incorporated by reference to Exhibit 99.3 to Amendment No. 1 to the Registration Statement on Form 40-F as filed on April 19, 2012, File No. 001-35447)

3.3

Notice of Articles and Certificate of Change of Name, dated September 1, 2016 (incorporated by reference to Exhibit 3.1 to the Form 8-K dated September 8, 2016)

31.1

Certification of the Chief Executive Officer required by Rule 13a-14(a) or Rule 15d-14(a) 

Trilogy Metals Inc.
For the Quarter Ended August 31, 2024

23

31.2

Certification of the Chief Financial Officer required by Rule 13a-14(a) or Rule 15d-14(a) 

32.1

Certification of the Chief Executive Officer pursuant to 18 U.S.C. Section 1350

32.2

Certification of the Chief Financial Officer pursuant to 18 U.S.C. Section 1350

101

Interactive Data Files

101.INS

Inline XBRL Instance Document

101.SCH

Inline XBRL Taxonomy Extension Schema Document

101.CAL

Inline XBRL Taxonomy Extension Calculation Linkbase Document

101.DEF

Inline XBRL Taxonomy Extension Definition Linkbase Document

101.LAB

Inline XBRL Taxonomy Extension Label Linkbase Document

101.PRE

Inline XBRL Taxonomy Extension Presentation Linkbase Document

104

Cover Page Interactive Data File – the cover page interactive data file does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document

Trilogy Metals Inc.
For the Quarter Ended August 31, 2024

24

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Date: October 8, 2024

TRILOGY METALS INC.

By:   

/s/ Tony Giardini

Tony Giardini

President and Chief Executive Officer

By:   

/s/ Elaine M. Sanders

Elaine M. Sanders

Vice President and Chief Financial Officer

Trilogy Metals Inc.
For the Quarter Ended August 31, 2024

25

Exhibit 31.1

CERTIFICATION PURSUANT TO

RULE 13a-14 OF THE SECURITIES EXCHANGE ACT OF 1934,

AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Tony Giardini, certify that:

1)I have reviewed this Quarterly Report on Form 10-Q of Trilogy Metals Inc.

2)Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3)Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4)The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5)The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:      October 8, 2024

By:

/s/ Tony Giardini

Tony Giardini

President and Chief Executive Officer

(principal executive officer)


Exhibit 31.2

CERTIFICATION PURSUANT TO

RULE 13a-14 OF THE SECURITIES EXCHANGE ACT OF 1934,

AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Elaine Sanders, certify that:

1.I have reviewed this Quarterly Report on Form 10-Q of Trilogy Metals Inc.

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:    October 8, 2024

By:

/s/ Elaine Sanders

Elaine Sanders

Vice President and Chief Financial Officer

(principal financial officer)


Exhibit 32.1

 

CERTIFICATION PURSUANT TO

18 U.S.C. §1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report on Form 10-Q of Trilogy Metals Inc. (the “Registrant”) for the period ended August 31, 2024 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Tony Giardini, President and Chief Executive Officer of the Registrant, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

(1)

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2)

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date:

October 8, 2024

By:

/s/ Tony Giardini

 

 

Tony Giardini

 

 

President and Chief Executive Officer

 

 

(principal executive officer)

 


Exhibit 32.2

 

 

CERTIFICATION PURSUANT TO

18 U.S.C. §1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report on Form 10-Q of Trilogy Metals Inc. (the “Registrant”) for the period ended August 31, 2024 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Elaine Sanders, Vice President and Chief Financial Officer of the Registrant, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

(1)

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2)

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date:

October 8, 2024

 

By:

/s/ Elaine Sanders

 

 

Elaine Sanders

 

 

Vice President and Chief Financial Officer

 

 

(principal financial officer)

 


v3.24.3
Document and Entity Information - shares
9 Months Ended
Aug. 31, 2024
Oct. 08, 2024
Document and Entity Information    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Aug. 31, 2024  
Document Transition Report false  
Securities Act File Number 1-35447  
Entity Registrant Name TRILOGY METALS INC.  
Entity Incorporation, State or Country Code A1  
Entity Tax Identification Number 98-1006991  
Entity Address, Address Line One Suite 901, 510 Burrard Street  
Entity Address, City or Town Vancouver  
Entity Address, State or Province BC  
Entity Address, Country CA  
Entity Address, Postal Zip Code V6C 3A8  
City Area Code 604  
Local Phone Number 638-8088  
Title of 12(b) Security Common Shares  
Trading Symbol TMQ  
Security Exchange Name NYSEAMER  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   160,902,814
Current Fiscal Year End Date --11-30  
Document Fiscal Year Focus 2024  
Document Fiscal Period Focus Q3  
Entity Central Index Key 0001543418  
Amendment Flag false  
v3.24.3
Interim Consolidated Balance Sheets - USD ($)
$ in Thousands
Aug. 31, 2024
Nov. 30, 2023
Current assets    
Cash and cash equivalents $ 25,738 $ 2,590
Accounts receivable 8 33
Deposits and prepaid amounts 352 259
Total current assets 26,098 2,882
Investment in Ambler Metals LLC (note 3) 108,114 135,021
Fixed assets   4
Right of use asset (note 5(a)) 164 113
Total assets 134,376 138,020
Current liabilities    
Accounts payable and accrued liabilities (note 4) 391 432
Current portion of lease liability 37 33
Total current liabilities 428 465
Long-term portion of lease liability 125  
Total liabilities 553 465
Shareholders' equity    
Share capital (note 6) - unlimited common shares authorized, no par value issued - 160,567,514 (2023 - 155,559,334) 190,200 187,886
Contributed surplus 118 118
Contributed surplus - options (note 6(a)) 28,741 28,237
Contributed surplus - units (note 6(b)) 3,528 3,127
Deficit (88,764) (81,813)
Total shareholders' equity 133,823 137,555
Total liabilities and shareholders' equity $ 134,376 $ 138,020
v3.24.3
Interim Consolidated Balance Sheets (Parenthetical) - $ / shares
3 Months Ended 12 Months Ended
Aug. 31, 2024
Nov. 30, 2023
Statement of Financial Position [Abstract]    
Unlimited common shares authorized Unlimited Unlimited
Common Stock, No Par Value $ 0 $ 0
Common Stock, Shares, Issued 160,567,514 155,559,334
v3.24.3
Interim Consolidated Statements of Loss and Comprehensive Loss - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Aug. 31, 2024
Aug. 31, 2023
Aug. 31, 2024
Aug. 31, 2023
Expenses        
Amortization $ 1 $ 2 $ 4 $ 6
Exploration expenses 28 22 28 23
Foreign exchange loss (gain) 2 3 3 1
General and administrative 293 278 1,027 1,014
Investor relations 15 18 46 71
Professional fees 138 139 530 897
Salaries 158 191 527 621
Salaries and directors expense - stock-based compensation 506 526 3,014 3,379
Total expenses 1,141 1,179 5,179 6,012
Other items        
Interest and other income (152) (37) (200) (83)
Services agreement income (22)   (47)  
Share of loss on equity investment (note 3(b)) 624 2,910 2,019 5,998
Loss and comprehensive loss for the period $ (1,591) $ (4,052) $ (6,951) $ (11,927)
Basic loss per common share $ (0.01) $ (0.03) $ (0.04) $ (0.08)
Diluted loss per common share $ (0.01) $ (0.03) $ (0.04) $ (0.08)
Basic weighted average number of common shares outstanding 160,542,286 155,550,284 159,466,414 151,572,299
Diluted weighted average number of common shares outstanding 160,542,286 155,550,284 159,466,414 151,572,299
v3.24.3
Interim Consolidated Statements of Changes in Shareholders' Equity - USD ($)
$ in Thousands
Common Stock [Member]
Contributed surplus.
Contributed surplus - options
Contributed surplus - units.
Retained Earnings [Member]
Total
Beginning Balance at Nov. 30, 2022 $ 182,178 $ 122 $ 27,352 $ 2,638 $ (66,862) $ 145,428
Beginning Balance (Shares) at Nov. 30, 2022 146,225,035          
Restricted Share Units $ 1,538 (1)   (1,537)    
Restricted Share Units (Shares) 2,346,366          
Joint venture contribution $ 111         111
Joint venture contribution (Shares) 143,505          
Services settled by common shares $ 4         4
Services settled by common shares (in shares) 7,793          
Stock-based compensation     520 1,700   2,220
Loss for the period         (5,072) (5,072)
Ending Balance at Feb. 28, 2023 $ 183,831 121 27,872 2,801 (71,934) 142,691
Ending Balance (Shares) at Feb. 28, 2023 148,722,699          
Beginning Balance at Nov. 30, 2022 $ 182,178 122 27,352 2,638 (66,862) 145,428
Beginning Balance (Shares) at Nov. 30, 2022 146,225,035          
Loss for the period           (11,927)
Ending Balance at Aug. 31, 2023 $ 187,715 118 28,111 2,858 (78,789) 140,013
Ending Balance (Shares) at Aug. 31, 2023 155,559,334          
Beginning Balance at Feb. 28, 2023 $ 183,831 121 27,872 2,801 (71,934) 142,691
Beginning Balance (Shares) at Feb. 28, 2023 148,722,699          
Shares issued for private placement, net of share issue cost $ 3,115         3,115
Shares issued for private placement, net of share issue cost (Shares) 5,854,545          
Restricted Share Units $ 121         121
Restricted Share Units (Shares) 213,463          
Deferred share units $ 468     (468)    
Deferred share units (Shares) 415,056          
Services settled by common shares $ 35         35
Services settled by common shares (in shares) 63,533          
Stock-based compensation     114 257   371
Loss for the period         (2,803) (2,803)
Ending Balance at May. 31, 2023 $ 187,570 121 27,986 2,590 (74,737) 143,530
Ending Balance (Shares) at May. 31, 2023 155,269,296          
Restricted Share Units $ 122         122
Restricted Share Units (Shares) 248,092          
Services settled by common shares $ 20         20
Services settled by common shares (in shares) 40,816          
Stock-based compensation     125 268   393
NovaGold deferred share units conversion $ 3 (3)        
NovaGold deferred share units conversion (Shares) 1,130          
Loss for the period         (4,052) (4,052)
Ending Balance at Aug. 31, 2023 $ 187,715 118 28,111 2,858 (78,789) 140,013
Ending Balance (Shares) at Aug. 31, 2023 155,559,334          
Beginning Balance at Nov. 30, 2023 $ 187,886 118 28,237 3,127 (81,813) 137,555
Beginning Balance (Shares) at Nov. 30, 2023 155,925,990          
Restricted Share Units $ 1,804     (1,804)    
Restricted Share Units (Shares) 3,633,065          
Joint venture contribution $ 112         112
Joint venture contribution (Shares) 143,507          
Services settled by common shares $ 30         30
Services settled by common shares (in shares) 64,368          
Stock-based compensation     318 1,681   1,999
Loss for the period         (3,601) (3,601)
Ending Balance at Feb. 29, 2024 $ 189,832 118 28,555 3,004 (85,414) 136,095
Ending Balance (Shares) at Feb. 29, 2024 159,766,930          
Beginning Balance at Nov. 30, 2023 $ 187,886 118 28,237 3,127 (81,813) 137,555
Beginning Balance (Shares) at Nov. 30, 2023 155,925,990          
Restricted Share Units (Shares) 4,312,432          
Joint venture contribution (Shares) 143,507          
Services settled by common shares $ 90          
Services settled by common shares (in shares) 185,585          
Loss for the period           (6,951)
Ending Balance at Aug. 31, 2024 $ 190,200 118 28,741 3,528 (88,764) 133,823
Ending Balance (Shares) at Aug. 31, 2024 160,567,514          
Beginning Balance at Feb. 29, 2024 $ 189,832 118 28,555 3,004 (85,414) 136,095
Beginning Balance (Shares) at Feb. 29, 2024 159,766,930          
Restricted Share Units $ 155     (155)    
Restricted Share Units (Shares) 353,347          
Services settled by common shares $ 30         30
Services settled by common shares (in shares) 66,511          
Stock-based compensation     92 417   509
Loss for the period         (1,759) (1,759)
Ending Balance at May. 31, 2024 $ 190,017 118 28,647 3,266 (87,173) 134,875
Ending Balance (Shares) at May. 31, 2024 160,186,788          
Restricted Share Units $ 153     (153)    
Restricted Share Units (Shares) 326,020          
Services settled by common shares $ 30         30
Services settled by common shares (in shares) 54,706          
Stock-based compensation     94 415   509
Loss for the period         (1,591) (1,591)
Ending Balance at Aug. 31, 2024 $ 190,200 $ 118 $ 28,741 $ 3,528 $ (88,764) $ 133,823
Ending Balance (Shares) at Aug. 31, 2024 160,567,514          
v3.24.3
Interim Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
9 Months Ended
Aug. 31, 2024
Aug. 31, 2023
Cash flows used in operating activities    
Net Income (Loss) $ (6,951) $ (11,927)
Adjustments to reconcile net loss to cash flows in operating activities    
Amortization 4 6
Consulting fees settled by common shares 90 86
Office lease accounting 76 (9)
Loss on equity investment in Ambler Metals LLC (note 3(b)) 2,019 5,998
Unrealized foreign exchange (gain) loss   5
Stock-based compensation 3,014 3,379
Net change in non-cash working capital    
Decrease in accounts receivable 25 7
Decrease in deposits and prepaid amounts (93) (137)
Increase in accounts payable and accrued liabilities (38) (42)
Total cash flows used in operating activities (1,854) (2,634)
Cash flows from financing activities    
Issuance of common shares, net of share issue cost (note 6(a))   3,115
Total cash flows from financing activities   3,115
Cash flows from investing activities    
Return of capital from Ambler Metals LLC (note 3(c)) 25,000  
Total cash flows from (used in) investing activities 25,000  
Change in cash 23,146 481
Effect of exchange rate on cash 2 (5)
Cash and cash equivalents - beginning of the period 2,590 2,573
Cash and cash equivalents - end of the period $ 25,738 $ 3,049
v3.24.3
Nature of operations
9 Months Ended
Aug. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Nature of operations

1)    Nature of operations

Trilogy Metals Inc. (“Trilogy” or the “Company”) was incorporated in British Columbia, Canada under the Business Corporations Act (British Columbia) on April 27, 2011. The Company is engaged in the exploration and development of mineral properties, through our equity investee (see note 3), with a focus on the Upper Kobuk Mineral Projects (“UKMP”), including the Arctic and Bornite Projects located in Northwest Alaska in the United States of America (“US”). The Company also conducts early-stage exploration through a wholly owned subsidiary, 995 Exploration Inc.  

v3.24.3
Summary of significant accounting policies
9 Months Ended
Aug. 31, 2024
Accounting Policies [Abstract]  
Summary of significant accounting policies

2)    Summary of significant accounting policies

Basis of presentation

These condensed interim consolidated financial statements have been prepared using accounting principles generally accepted in the United States (“U.S. GAAP”) and include the accounts of Trilogy and its wholly owned subsidiaries, NovaCopper US Inc. (dba “Trilogy Metals US”) and 995 Exploration Inc. All intercompany transactions are eliminated on consolidation. For variable interest entities (“VIEs”) where Trilogy is not the primary beneficiary, we use the equity method of accounting.

All figures are in United States dollars unless otherwise noted. References to CDN$ refer to amounts in Canadian dollars.

These condensed interim consolidated financial statements include all adjustments necessary for the fair statement of the Company’s financial position as of August 31, 2024 and our results of operations and cash flows for the nine-month periods ended August 31, 2024 and August 31, 2023. The results of operations for the nine-month period ended August 31, 2024 are not necessarily indicative of the results to be expected for the fiscal year ending November 30, 2024.

As these condensed interim consolidated financial statements do not contain all of the disclosures required by U.S. GAAP for annual financial statements, these condensed interim consolidated financial statements should be read in conjunction with the annual financial statements and related notes included in our Annual Report on Form 10-K for the fiscal year ended November 30, 2023, filed with the U.S. Securities and Exchange Commission (“SEC”) and Canadian securities regulatory authorities on February 9, 2024.

These condensed interim consolidated financial statements were approved by the Company’s Audit Committee on behalf of the Board of Directors for issue on October 7, 2024.

Use of estimates and measurement uncertainties

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions of future events that affect the reported amount of assets and liabilities and disclosure of contingent liabilities at the date of the financial statements, and the reported amounts of expenditures during the period. Significant estimates include the measurement of income taxes and the valuation of stock-based compensation. Actual results could differ materially from those reported.

Management assesses the possibility of impairment in the carrying value of its equity method investment in Ambler Metals whenever events or circumstances indicate that the carrying amount of the investment may not be recoverable.  Ambler Metals is a non-publicly traded equity investment owning exploration and development projects. Significant judgments are made in assessing the possibility of impairment. The Company assesses whether there has been a potential triggering event for other-than-temporary impairment by assessing the underlying assets of Ambler Metals for recoverability and assessing whether there has been a change in the development plan or strategy for the projects.  If the Company concludes there is sufficient evidence for an other-than-temporary impairment, an assessment of fair value is performed.  If the underlying assets are not recoverable, the Company will record an impairment charge equal to the difference between the carrying amount of the equity investment and its fair value.  This assessment is subjective and requires consideration at each period end.

v3.24.3
Investment in Ambler Metals LLC
9 Months Ended
Aug. 31, 2024
Investment in Ambler Metals LLC  
Investment in Ambler Metals LLC

3)    Investment in Ambler Metals LLC

(a)

Formation of Ambler Metals LLC

On February 11, 2020, the Company completed the formation of a 50/50 joint venture named Ambler Metals LLC (“Ambler Metals”) with South32 Limited (“South32”). As part of the formation of the joint venture, Trilogy contributed all its assets associated with the UKMP, including the Arctic and Bornite Projects, while South32 contributed cash of $145.0 million, resulting in each party’s subsidiaries directly owning a 50% interest in Ambler Metals.

Ambler Metals is a company jointly controlled by Trilogy and South32 through a four-member board, of which two members are appointed by Trilogy based on its 50% equity interest. All significant decisions related to the UKMP require the approval of both companies. We determined that Ambler Metals is a VIE because it is expected to need additional funding from its owners for its significant activities. However, we concluded that we are not the primary beneficiary of Ambler Metals as the power to direct its activities, through its board, is shared under the Ambler Metals LLC limited liability company agreement. As we have significant influence over Ambler Metals through our representation on its board, we use the equity method of accounting for our investment in Ambler Metals. Our maximum exposure to loss in this entity is limited to the carrying amount of our investment in Ambler Metals, which, as of August 31, 2024, totaled $108.1 million (2023 - $136.9 million).

(b)

Carrying value of equity method investment

Trilogy recognized, based on its 50% ownership interest in Ambler Metals, an equity loss equivalent to its pro rata share of Ambler Metals’ comprehensive loss of $1.2 million for the three-month period ending August 31, 2024 (2023 - $5.8 million) and $4.0 million for the nine-month period ending August 31, 2024 (2023 - $12.0 million).  During the nine-month period ending August 31, 2024, Trilogy made a $112,000 equity contribution to Ambler Metals through the issuance of 143,507 common shares of the Company as part of the long-term incentive compensation for Ambler Metals executives. Likewise, South32 made an equivalent equity contribution to Ambler Metals for $112,000 in cash for their 50% share. The carrying value of Trilogy’s 50% investment in Ambler Metals as at August 31, 2024 is summarized on the following table.

    

in thousands of dollars

$

  

November 30, 2023, Investment in Ambler Metals

135,021

Joint venture equity contribution

112

Return of capital

(25,000)

Share of loss on equity investment for the nine-month period ending August 31, 2024

(2,019)

August 31, 2024, Investment in Ambler Metals

108,114

(c)

The following table summarizes Ambler Metals’ Balance Sheet as at August 31, 2024.

    

in thousands of dollars

August 31, 2024

November 30, 2023

    

$

  

  

$

  

Total assets

41,888

97,180

Cash and cash equivalents

9,848

63,829

Mineral properties

30,899

30,899

Total liabilities

(1,455)

(2,931)

Accounts payable and accrued liabilities

(1,209)

(2,500)

Members' equity (total assets less total liabilities)

40,433

94,249

Ambler Metals’ cash and cash equivalents are held at one bank of which the majority is uninsured.  During the second and third quarters, Ambler Metals returned $50 million of excess cash to the members.  

(d) The following table summarizes Ambler Metals' loss for the three-month and nine-month periods ended August 31, 2024 and August 31, 2023.

in thousands of dollars

Three months ended

Nine months ended

August 31, 2024

August 31, 2023

August 31, 2024

August 31, 2023

  

$

  

  

$

  

  

$

  

  

$

  

Depreciation

38

38

113

113

Corporate salaries and wages

49

478

411

1,417

General and administrative

93

43

343

389

Mineral property expense

1,024

5,210

3,348

10,002

Professional fees

325

181

755

397

Foreign exchange loss

(6)

2

(3)

Interest and other income

(281)

(125)

(933)

(319)

Comprehensive loss

1,248

5,819

4,039

11,996

(e) Related party transactions

During the nine-month period ended August 31, 2024, the Company charged $47,000 (2023 - $Nil) related to human resources and accounting services in connection with a service agreement between the Company and Ambler Metals. In addition, the Company received payments of $64,000 (2023 - $Nil) related to operating expenses paid on behalf of Ambler Metals pursuant to the service agreement.

v3.24.3
Accounts payable and accrued liabilities
9 Months Ended
Aug. 31, 2024
Accounts payable and accrued liabilities.  
Accounts payable and accrued liabilities

4)    Accounts payable and accrued liabilities

in thousands of dollars

August 31, 2024

November 30, 2023

  

$

  

  

$

  

Trade accounts payable

51

146

Accrued liabilities

 

88

 

54

Accrued salaries and vacation

 

252

 

232

Accounts payable and accrued liabilities

 

391

 

432

Subsequent to the end of the third quarter, on September 3, 2024, approximately $153,000 of accrued salaries was settled through the issuance of common shares of the Company.

v3.24.3
Leases
9 Months Ended
Aug. 31, 2024
Leases  
Leases

5)    Leases

(a)Right-of-use asset

in thousands of dollars

  

$

  

Balance as at November 30, 2023

113

Net amortization for lease ended June 30, 2024

(113)

ROU assets recognized for lease commenced July 1, 2024

170

Net amortization for lease commenced July 1, 2024

(6)

Balance as at August 31, 2024

164

The Company’s previous office lease ended on June 30, 2024.  The Company entered into a new office lease commencing on July 1, 2024, with a 4-year term ending in June 2028, and with no renewal option.  During the quarter ended August 31, 2024, the Company recognized a ROU asset of $170,000 for the new office lease.

(b)Lease liabilities

The Company’s lease arrangement consists of an operating lease for our office space ending in June 2028. There are no extension options.

Total lease expense recorded within general and administrative expenses was comprised of the following components:

    

in thousands of dollars

Nine months ended

Nine months ended

August 31, 2024

August 31, 2023

$

  

  

$

  

Operating lease costs

122

140

Variable lease costs

103

103

Total lease expense

225

243

Variable lease costs consist primarily of the Company’s portion of operating costs associated with the office space lease as the Company elected to apply the practical expedient not to separate lease and non-lease components.

As at August 31, 2024, the weighted-average remaining lease term is 3.8 years and the weighted-average discount rate is 9%. Significant judgment was used in the determination of the incremental borrowing rate which included estimating the Company’s credit rating.

Supplemental cash and non-cash information relating to our leases during the nine-month period ending August 31, 2024 are as follows:

Cash paid for amounts included in the measurement of lease liabilities was $45,561, of which $33,159 related to the office lease that expired on June 30, 2024 and $12,402 related to the new office lease that commenced on July 1, 2024.

Future minimum payments relating to the lease recognized in our balance sheet as of August 31, 2024 are as follows:

    

in thousands of dollars

August 31, 2024

 

Fiscal year

$

  

2024

 

13

2025

 

50

2026

 

51

2027

 

51

2028

 

30

Total undiscounted lease payments

 

195

Effect of discounting

 

(33)

Present value of lease payments recognized as lease liability

 

162

v3.24.3
Share capital
9 Months Ended
Aug. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Share capital

6)    Share capital

Authorized:

unlimited common shares, no par value

in thousands of dollars, except share amounts

Number of shares

Ascribed value

    

  

  

$

  

November 30, 2023

 

155,925,990

187,886

Restricted Share Units

4,312,432

2,112

Services settled by common shares

185,585

90

Joint venture equity contribution (note 3(a))

143,507

112

August 31, 2024, issued and outstanding

160,567,514

190,200

(a)

Stock options

During the three-month period ended February 29, 2024, the Company granted 2,775,000 stock options (2023 - 3,230,000 stock options) at an exercise price of CDN$0.59 (2023 - CDN$0.78) to employees, consultants and directors exercisable for a period of five years with various vesting terms from immediate vesting to vesting over a two-year period. The fair value attributable to each of these option grants was CDN$0.27 (2023 - CDN$0.37).  No grants were made during the three-month periods ended May 31, 2024 or August 31, 2024.

For the three-month period ended August 31, 2024, Trilogy recognized a stock-based compensation charge of $0.1 million (2023 - $0.1 million) for options granted to directors, employees and service providers, net of estimated forfeitures. For the nine-month period ended August 31, 2024, Trilogy recognized a stock-based compensation charge of $0.5 million (2023 - $0.8 million) for options granted to directors, employees and service providers, net of estimated forfeitures.

The fair value of the stock options recognized in the period has been estimated using the Black-Scholes option pricing model.

Assumptions used in the pricing model for the nine-month period ended August 31, 2024 are as provided below.

    

August 31, 2024

Risk-free interest rates

 

3.84%

Exercise price

 

CDN$0.59

Expected life

 

3 years

Expected volatility

 

65.5%

Expected dividends

 

Nil

As at August 31, 2024, there were 2,533,339 non-vested options outstanding with a weighted average exercise price of CDN$0.66. The value of non-vested stock option expense not yet recognized was $0.2 million of which approximately $0.1 million will be recognized during the quarter ending November 30, 2024 and the remainder throughout the next fiscal year.

A summary of the Company’s stock options outstanding and changes during the nine-month period ended August 31, 2024 is as follows:

August 31, 2024

Weighted average

exercise price

    

Number of options

  

  

CDN$

  

Balance – beginning of the period

 

12,649,400

2.15

Granted

 

2,775,000

0.59

Expired

 

(1,107,500)

2.96

Balance – end of the period

 

14,316,900

1.78

There were no stock options exercised during the nine-month period ended August 31, 2024.

The following table summarizes information about the stock options outstanding at August 31, 2024.

Outstanding

Exercisable

Unvested

 

Weighted

Weighted

 

Number of

Weighted

average

Number of

average

Number of

 

outstanding

average years

exercise price

exercisable

exercise price

unvested

Range of exercise price - CDN

  

options

  

  

to expiry

  

  

CDN$

  

  

options

  

  

CDN$

  

  

options  

  

$0.59 to $1.00

 

5,955,000

3.73

0.69

3,421,661

0.72

2,533,339

$2.01 to $3.00

 

7,016,900

1.21

2.47

7,016,900

2.47

$3.01 to $3.02

1,345,000

0.32

3.02

1,345,000

3.02

14,316,900

2.18

1.78

11,783,561

2.03

2,533,339

The aggregate intrinsic value of vested stock options (the market value less the exercise price) at August 31, 2024 was $Nil (2023 - $Nil) and the aggregate intrinsic value of exercised options for the nine-month period ending August 31, 2024 was $Nil (2023 - $Nil).

(b)

Restricted Share Units and Deferred Share Units

The Company has a Restricted Share Unit Plan (“RSU Plan”) to provide long-term incentives to employees and consultants, a Non-Executive Director Deferred Share Unit Plan (“DSU Plan”), and a Non-Executive Directors Fixed Deferred Share Unit Plan (“Fixed DSU Plan”) to offset cash payments for fees to directors.  Awards under the RSU Plan, DSU Plan and Fixed DSU Plan will be settled in common shares of the Company with each restricted share unit (“RSU”) and deferred share unit (“DSU”) entitling the holder to receive one common share of the Company.  All units are accounted for as equity-settled awards.

A summary of the Company’s unit plans and changes during the nine-month period ending August 31, 2024 is as follows:

    

Number of RSUs

  

  

Number of DSUs

  

  

Number of Fixed DSUs

  

Balance – beginning of the period

1,610,638

 

2,428,701

Granted

 

5,705,718

551,676

Vested/Converted

 

(4,498,017)

Balance – end of the period

 

2,818,339

 

2,980,377

For the three-month period ending August 31, 2024, Trilogy recognized a combined RSU and DSU stock-based compensation charge of $0.2 million (2023 - $0.2 million), net of estimated forfeitures. For the nine-month period ending August 31, 2024, Trilogy recognized a combined RSU and DSU stock-based compensation charge of $1.8 million (2023 - $2.0 million), net of estimated forfeitures.

v3.24.3
Financial instruments
9 Months Ended
Aug. 31, 2024
Financial instruments  
Financial instruments

7)    Financial instruments

The Company is exposed to a variety of risks arising from financial instruments. These risks and management’s objectives, policies and procedures for managing these risks are disclosed as follows.

The Company’s financial instruments consist of cash and cash equivalents, accounts receivable, deposits, and accounts payable and accrued liabilities. The fair value of the Company’s financial instruments approximates their carrying value due to the short-term nature of their maturity. The Company’s financial instruments initially measured at fair value and then held at amortized cost include cash and cash equivalents, accounts receivable, deposits, and accounts payable and accrued liabilities.

Financial risk management

The Company’s activities expose it to certain financial risks, including currency risk, credit risk, liquidity risk, interest risk and price risk.

(a)

Currency risk

Currency risk is the risk of a fluctuation in financial asset and liability settlement amounts due to a change in foreign exchange rates. The Company operates in the United States and Canada. The Company’s exposure to currency risk at August 31, 2024 is limited to the Canadian dollar balances consisting of cash of approximately CDN$11,000, accounts receivable of approximately CDN$11,000 and accounts payable of approximately CDN$34,000. Based on a 10% change in the US-Canadian exchange rate, assuming all other variables remain constant, the Company’s net loss would change by approximately $1,000.

(b)

Credit risk

Credit risk is the risk of an unexpected loss if a customer or third party to a financial instrument fails to meet its contractual obligations. The Company holds cash with a Canadian chartered financial institution of which the majority is uninsured as at August 31, 2024. The Company’s only significant exposure to credit risk is equal to the balance of cash as recorded in the financial statements.

(c)

Liquidity risk

Liquidity risk is the risk that the Company will encounter difficulties raising funds to meet its financial obligations as they fall due. The Company is in the exploration stage and does not have cash inflows from operations; therefore, the Company manages liquidity risk through the management of its capital structure and financial leverage.

Contractually obligated undiscounted cash flow requirements as at August 31, 2024 are as follows:

in thousands of dollars

  

  

Total

  

  

< 1 Year

  

  

1–2 Years

  

  

2–5 Years

  

  

Thereafter

  

$

$

$

$

$

Accounts payable and accrued liabilities

 

391

 

391

 

Office lease

 

195

50

102

43

 

 

586

 

441

 

102

43

Included in accounts payable and accrued liabilities approximately $153,000 is for accrued salaries that were settled, subsequent to the end of the third quarter, on September 3, 2024, by the way of a grant of RSUs which was paid out through the issuance of common shares of the Company (note 8).

(d)

Interest rate risk

Interest rate risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in market interest rates. The Company is exposed to interest rate risk with respect to interest earned on cash. Based on balances as at August 31, 2024 of approximately $25 million, a 1% change in interest rates would result in a change of approximately $250,000 over a one year period, assuming all other variables remain constant.

As we are currently in the exploration phase, none of our financial instruments are exposed to commodity price risk; however, our ability to obtain long-term financing and its economic viability could be affected by commodity price volatility.

v3.24.3
Subsequent event
9 Months Ended
Aug. 31, 2024
Subsequent Events [Abstract]  
Subsequent event

8) Subsequent events

On September 3, 2024, pursuant to previous elections, the Board of Directors were granted 153,035 DSUs in settlement of approximately $78,250 of director fees and senior management were granted 298,263 RSUs in lieu of cash salaries of approximately $153,000, all vesting immediately. The grants were in support of continued cash preservation efforts.

v3.24.3
Pay vs Performance Disclosure - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Aug. 31, 2024
May 31, 2024
Feb. 29, 2024
Aug. 31, 2023
May 31, 2023
Feb. 28, 2023
Aug. 31, 2024
Aug. 31, 2023
Pay vs Performance Disclosure                
Net Income (Loss) $ (1,591) $ (1,759) $ (3,601) $ (4,052) $ (2,803) $ (5,072) $ (6,951) $ (11,927)
v3.24.3
Insider Trading Arrangements
3 Months Ended
Aug. 31, 2024
Trading Arrangements, by Individual  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
v3.24.3
Summary of significant accounting policies (Policies)
9 Months Ended
Aug. 31, 2024
Accounting Policies [Abstract]  
Basis of presentation

Basis of presentation

These condensed interim consolidated financial statements have been prepared using accounting principles generally accepted in the United States (“U.S. GAAP”) and include the accounts of Trilogy and its wholly owned subsidiaries, NovaCopper US Inc. (dba “Trilogy Metals US”) and 995 Exploration Inc. All intercompany transactions are eliminated on consolidation. For variable interest entities (“VIEs”) where Trilogy is not the primary beneficiary, we use the equity method of accounting.

All figures are in United States dollars unless otherwise noted. References to CDN$ refer to amounts in Canadian dollars.

These condensed interim consolidated financial statements include all adjustments necessary for the fair statement of the Company’s financial position as of August 31, 2024 and our results of operations and cash flows for the nine-month periods ended August 31, 2024 and August 31, 2023. The results of operations for the nine-month period ended August 31, 2024 are not necessarily indicative of the results to be expected for the fiscal year ending November 30, 2024.

As these condensed interim consolidated financial statements do not contain all of the disclosures required by U.S. GAAP for annual financial statements, these condensed interim consolidated financial statements should be read in conjunction with the annual financial statements and related notes included in our Annual Report on Form 10-K for the fiscal year ended November 30, 2023, filed with the U.S. Securities and Exchange Commission (“SEC”) and Canadian securities regulatory authorities on February 9, 2024.

These condensed interim consolidated financial statements were approved by the Company’s Audit Committee on behalf of the Board of Directors for issue on October 7, 2024.

Use of estimates and measurement uncertainties

Use of estimates and measurement uncertainties

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions of future events that affect the reported amount of assets and liabilities and disclosure of contingent liabilities at the date of the financial statements, and the reported amounts of expenditures during the period. Significant estimates include the measurement of income taxes and the valuation of stock-based compensation. Actual results could differ materially from those reported.

Management assesses the possibility of impairment in the carrying value of its equity method investment in Ambler Metals whenever events or circumstances indicate that the carrying amount of the investment may not be recoverable.  Ambler Metals is a non-publicly traded equity investment owning exploration and development projects. Significant judgments are made in assessing the possibility of impairment. The Company assesses whether there has been a potential triggering event for other-than-temporary impairment by assessing the underlying assets of Ambler Metals for recoverability and assessing whether there has been a change in the development plan or strategy for the projects.  If the Company concludes there is sufficient evidence for an other-than-temporary impairment, an assessment of fair value is performed.  If the underlying assets are not recoverable, the Company will record an impairment charge equal to the difference between the carrying amount of the equity investment and its fair value.  This assessment is subjective and requires consideration at each period end.

v3.24.3
Investment in Ambler Metals LLC (Tables)
9 Months Ended
Aug. 31, 2024
Investment in Ambler Metals LLC  
Schedule of equity investment

    

in thousands of dollars

$

  

November 30, 2023, Investment in Ambler Metals

135,021

Joint venture equity contribution

112

Return of capital

(25,000)

Share of loss on equity investment for the nine-month period ending August 31, 2024

(2,019)

August 31, 2024, Investment in Ambler Metals

108,114

Schedule of Ambler Metals LLC's Balance Sheet

    

in thousands of dollars

August 31, 2024

November 30, 2023

    

$

  

  

$

  

Total assets

41,888

97,180

Cash and cash equivalents

9,848

63,829

Mineral properties

30,899

30,899

Total liabilities

(1,455)

(2,931)

Accounts payable and accrued liabilities

(1,209)

(2,500)

Members' equity (total assets less total liabilities)

40,433

94,249

Schedule of Ambler Metals LLC's net loss

in thousands of dollars

Three months ended

Nine months ended

August 31, 2024

August 31, 2023

August 31, 2024

August 31, 2023

  

$

  

  

$

  

  

$

  

  

$

  

Depreciation

38

38

113

113

Corporate salaries and wages

49

478

411

1,417

General and administrative

93

43

343

389

Mineral property expense

1,024

5,210

3,348

10,002

Professional fees

325

181

755

397

Foreign exchange loss

(6)

2

(3)

Interest and other income

(281)

(125)

(933)

(319)

Comprehensive loss

1,248

5,819

4,039

11,996

v3.24.3
Accounts payable and accrued liabilities (Tables)
9 Months Ended
Aug. 31, 2024
Accounts payable and accrued liabilities.  
Schedule of accounts payable and accrued liabilities

in thousands of dollars

August 31, 2024

November 30, 2023

  

$

  

  

$

  

Trade accounts payable

51

146

Accrued liabilities

 

88

 

54

Accrued salaries and vacation

 

252

 

232

Accounts payable and accrued liabilities

 

391

 

432

v3.24.3
Leases (Tables)
9 Months Ended
Aug. 31, 2024
Leases  
Schedule of right-of-use asset

in thousands of dollars

  

$

  

Balance as at November 30, 2023

113

Net amortization for lease ended June 30, 2024

(113)

ROU assets recognized for lease commenced July 1, 2024

170

Net amortization for lease commenced July 1, 2024

(6)

Balance as at August 31, 2024

164

Schedule of lease expenses

    

in thousands of dollars

Nine months ended

Nine months ended

August 31, 2024

August 31, 2023

$

  

  

$

  

Operating lease costs

122

140

Variable lease costs

103

103

Total lease expense

225

243

Schedule of future minimum payments

    

in thousands of dollars

August 31, 2024

 

Fiscal year

$

  

2024

 

13

2025

 

50

2026

 

51

2027

 

51

2028

 

30

Total undiscounted lease payments

 

195

Effect of discounting

 

(33)

Present value of lease payments recognized as lease liability

 

162

v3.24.3
Share capital (Tables)
9 Months Ended
Aug. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of common stock outstanding roll forward

in thousands of dollars, except share amounts

Number of shares

Ascribed value

    

  

  

$

  

November 30, 2023

 

155,925,990

187,886

Restricted Share Units

4,312,432

2,112

Services settled by common shares

185,585

90

Joint venture equity contribution (note 3(a))

143,507

112

August 31, 2024, issued and outstanding

160,567,514

190,200

Schedule of assumptions used in the pricing model

    

August 31, 2024

Risk-free interest rates

 

3.84%

Exercise price

 

CDN$0.59

Expected life

 

3 years

Expected volatility

 

65.5%

Expected dividends

 

Nil

Summary of the company's stock option plan

August 31, 2024

Weighted average

exercise price

    

Number of options

  

  

CDN$

  

Balance – beginning of the period

 

12,649,400

2.15

Granted

 

2,775,000

0.59

Expired

 

(1,107,500)

2.96

Balance – end of the period

 

14,316,900

1.78

Summary of information about stock options

Outstanding

Exercisable

Unvested

 

Weighted

Weighted

 

Number of

Weighted

average

Number of

average

Number of

 

outstanding

average years

exercise price

exercisable

exercise price

unvested

Range of exercise price - CDN

  

options

  

  

to expiry

  

  

CDN$

  

  

options

  

  

CDN$

  

  

options  

  

$0.59 to $1.00

 

5,955,000

3.73

0.69

3,421,661

0.72

2,533,339

$2.01 to $3.00

 

7,016,900

1.21

2.47

7,016,900

2.47

$3.01 to $3.02

1,345,000

0.32

3.02

1,345,000

3.02

14,316,900

2.18

1.78

11,783,561

2.03

2,533,339

Schedule of restricted share Units and deferred share units plans

    

Number of RSUs

  

  

Number of DSUs

  

  

Number of Fixed DSUs

  

Balance – beginning of the period

1,610,638

 

2,428,701

Granted

 

5,705,718

551,676

Vested/Converted

 

(4,498,017)

Balance – end of the period

 

2,818,339

 

2,980,377

v3.24.3
Financial instruments (Tables)
9 Months Ended
Aug. 31, 2024
Financial instruments  
Schedule of contractually obligated cash flow requirements

in thousands of dollars

  

  

Total

  

  

< 1 Year

  

  

1–2 Years

  

  

2–5 Years

  

  

Thereafter

  

$

$

$

$

$

Accounts payable and accrued liabilities

 

391

 

391

 

Office lease

 

195

50

102

43

 

 

586

 

441

 

102

43

v3.24.3
Investment in Ambler Metals LLC - Financial information (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Aug. 31, 2024
Aug. 31, 2023
Aug. 31, 2024
Aug. 31, 2023
Nov. 30, 2023
The carrying value of equity method investment          
Share of loss on equity investment $ (624) $ (2,910) $ (2,019) $ (5,998)  
Investment in Ambler Metals 108,114   108,114   $ 135,021
Assets [Abstract]          
Total assets 134,376   134,376   138,020
Cash and cash equivalents 25,738   25,738   2,590
Liabilities [Abstract]          
Total liabilities (553)   (553)   (465)
Operating Income (Loss) [Abstract]          
General and administrative 293 278 1,027 1,014  
Professional Fees 138 139 530 897  
Foreign exchange loss 2 3 3 1  
Equity Method Investment, Nonconsolidated Investee or Group of Investees [Member]          
Assets [Abstract]          
Total assets 41,888   41,888   97,180
Cash and cash equivalents 9,848   9,848   63,829
Mineral properties 30,899   30,899   30,899
Liabilities [Abstract]          
Total liabilities (1,455)   (1,455)   (2,931)
Accounts payable and accrued liabilities (1,209)   (1,209)   (2,500)
Members' equity (total assets less total liabilities) 40,433   40,433   94,249
Operating Income (Loss) [Abstract]          
Depreciation 38 38 113 113  
Corporate salaries and wages 49 478 411 1,417  
General and administrative 93 43 343 389  
Mineral property expense 1,024 5,210 3,348 10,002  
Professional Fees 325 181 755 397  
Foreign exchange loss   (6) 2 (3)  
Interest and other income 281 125 933 319  
Comprehensive loss 1,248 $ 5,819 4,039 $ 11,996  
Ambler Metals LLC          
The carrying value of equity method investment          
Investment in Ambler Metals         $ 135,021
Joint venture, contributed amount 112   112    
Return of capital     (25,000)    
Share of loss on equity investment     (2,019)    
Investment in Ambler Metals $ 108,114   $ 108,114    
v3.24.3
Investment in Ambler Metals LLC - Narrative (Details)
3 Months Ended 9 Months Ended
Feb. 11, 2020
USD ($)
Owner
Aug. 31, 2024
USD ($)
shares
May 31, 2024
USD ($)
Aug. 31, 2023
USD ($)
Aug. 31, 2024
USD ($)
shares
Aug. 31, 2023
USD ($)
Nov. 30, 2023
USD ($)
Schedule of Equity Method Investments [Line Items]              
Cash and cash equivalents   $ 25,738,000     $ 25,738,000   $ 2,590,000
Excess cash returned to members         25,000,000    
Loss for the year   (1,591,000)   $ (4,052,000) (6,951,000) $ (11,927,000)  
Investment in Ambler Metals   108,114,000     108,114,000   135,021,000
Ambler Metals LLC              
Schedule of Equity Method Investments [Line Items]              
Joint venture, contributed amount   112,000     112,000    
Contribution made to joint venture   $ 112,000     $ 112,000    
Joint venture contribution made in common shares | shares   143,507     143,507    
Percentage of ownership 50.00% 50.00%     50.00%    
Excess cash returned to members   $ 50,000,000 $ 50,000,000        
Loss for the year   (1,200,000)   (5,800,000) $ (4,000,000.0) (12,000,000.0)  
Number of board members | Owner 4            
Number of members appointed by Trilogy | Owner 2            
Investment in Ambler Metals   108,114,000     108,114,000    
Maximum exposure to loss   108,100,000   $ 136,900,000 108,100,000 136,900,000  
Fair value ascribed to Ambler Metals LLC interest             $ 135,021,000
South32 | Ambler Metals LLC              
Schedule of Equity Method Investments [Line Items]              
Contribution made to joint venture   $ 112,000     $ 112,000    
Percentage of ownership 50.00% 50.00%     50.00%    
Ambler Metals              
Schedule of Equity Method Investments [Line Items]              
Human resources and accounting services in connection with a service agreement         $ 47,000 0  
Operating expenses         $ 64,000 $ 0  
South32              
Schedule of Equity Method Investments [Line Items]              
Contribution made to joint venture $ 145,000,000.0            
v3.24.3
Accounts payable and accrued liabilities (Details) - USD ($)
Sep. 03, 2024
Aug. 31, 2024
Nov. 30, 2023
Subsequent Event [Line Items]      
Trade accounts payable   $ 51,000 $ 146,000
Accrued liabilities   88,000 54,000
Accrued salaries and vacation   252,000 232,000
Accounts payable and accrued liabilities   $ 391,000 $ 432,000
Subsequent Event [Member]      
Subsequent Event [Line Items]      
Accrued salaries and vacation $ 153,000    
v3.24.3
Leases - Narrative (Details) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended
Jul. 31, 2024
Jun. 30, 2024
Aug. 31, 2024
Aug. 31, 2024
Leases        
ROU assets recognized for lease commenced     $ 170,000  
Lessee, Operating Lease, Existence of Option to Extend [true false]     false  
Remaining lease term     4 years 4 years
Weighted-average remaining lease term     3 years 9 months 18 days 3 years 9 months 18 days
Weighted-average discount rate     9.00% 9.00%
Cash paid for amounts included in the measurement of lease liabilities $ 12,402 $ 33,159   $ 45,561
v3.24.3
Leases - Right of use asset (Details) - USD ($)
3 Months Ended
Aug. 31, 2024
May 31, 2024
Leases    
Net amortization for lease $ (6,000) $ 113,000
ROU assets recognized for lease commenced 170,000  
Right-of-use asset, Ending balance $ 164,000  
v3.24.3
Leases - Lease liabilities (Details) - USD ($)
$ in Thousands
9 Months Ended
Aug. 31, 2024
Aug. 31, 2023
Leases    
Operating lease costs $ 122 $ 140
Variable lease costs 103 103
Total lease expense $ 225 $ 243
v3.24.3
Leases - Future minimum payments (Details)
$ in Thousands
Aug. 31, 2024
USD ($)
Future minimum payments  
2024 $ 13
2025 50
2026 51
2027 51
2028 30
Total undiscounted lease payments 195
Effect of discounting (33)
Present value of lease payments recognized as lease liability $ 162
v3.24.3
Share capital - Narrative (Details)
$ / shares in Units, $ in Thousands
3 Months Ended 9 Months Ended
Nov. 30, 2024
USD ($)
Aug. 31, 2024
USD ($)
$ / shares
shares
May 31, 2024
USD ($)
shares
Feb. 29, 2024
USD ($)
shares
Feb. 29, 2024
$ / shares
Aug. 31, 2023
USD ($)
May 31, 2023
USD ($)
shares
Feb. 28, 2023
USD ($)
shares
Feb. 28, 2023
$ / shares
Aug. 31, 2024
USD ($)
$ / shares
shares
Aug. 31, 2024
USD ($)
$ / shares
$ / shares
shares
Aug. 31, 2023
USD ($)
Aug. 31, 2024
$ / shares
Nov. 30, 2023
$ / shares
shares
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                            
Number of shares, conversion                   1        
Non-vested stock options outstanding   14,316,900               14,316,900 14,316,900      
Private placement, net proceeds | $                       $ 3,115    
Stock-based compensation | $   $ (509) $ (509) $ (1,999)   $ (393) $ (371) $ (2,220)            
Weighted average exercise price options outstanding | $ / shares   $ 1.78               $ 1.78 $ 1.78      
Forecast [Member]                            
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                            
Stock option expense recognized | $ $ 100                          
Common Stock [Member]                            
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                            
Common stock committed for issuance   160,567,514               160,567,514 160,567,514     155,925,990
Shares issued for private placement, net of share issue cost (Shares)             5,854,545              
Nonvested Options                            
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                            
Non-vested stock options outstanding   2,533,339               2,533,339 2,533,339      
Weighted average exercise price options outstanding | $ / shares                         $ 0.66  
Stock option expense not yet recognized | $   $ 200               $ 200 $ 200      
RSU and DSU                            
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                            
Stock-based compensation | $   $ 200       200                
DSUs                            
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                            
Stock-based compensation | $                   $ 1,800   2,000    
Stock options                            
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                            
Non-vested stock options outstanding   14,316,900               14,316,900 14,316,900     12,649,400
Weighted average exercise price options outstanding | $ / shares   $ 1.78               $ 1.78 $ 1.78     $ 2.15
Exercise of options, Number of shares                   0        
Stock options granted                   2,775,000        
Weighted-average exercise price | $ / shares                   $ 0.59        
Employees, consultants and directors                            
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                            
Stock options granted, expiration period       5 years       5 years            
Stock options granted   0 0 2,775,000       3,230,000            
Vesting period       2 years       2 years            
Weighted-average exercise price | $ / shares         $ 0.59       $ 0.78          
Stock options granted, weighted average fair value | $ / shares         $ 0.27       $ 0.37   $ 0.27      
Directors, employees and service providers | Stock options                            
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                            
Stock-based compensation | $   $ 100       $ 100       $ 500   $ 800    
v3.24.3
Share capital - Authorized unlimited common shares, no par value (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Aug. 31, 2024
May 31, 2024
Feb. 29, 2024
Aug. 31, 2023
May 31, 2023
Feb. 28, 2023
Aug. 31, 2024
Nov. 30, 2023
Class of Stock [Line Items]                
Unlimited common shares authorized Unlimited             Unlimited
Common Stock, No Par Value $ 0           $ 0 $ 0
Private Placement, net of share issue cost, Ascribed value         $ 3,115      
Services settled by common shares, Ascribed value $ 30 $ 30 $ 30 $ 20 $ 35 $ 4    
Number of shares, issued 160,567,514           160,567,514 155,559,334
Common Stock [Member]                
Class of Stock [Line Items]                
Private Placement, net of share issue cost, Number of shares         5,854,545      
Private Placement, net of share issue cost, Ascribed value         $ 3,115      
Restricted share units, Number of shares 326,020 353,347 3,633,065 248,092 213,463 2,346,366 4,312,432  
Restricted share units, Ascribed value             $ 2,112  
NovaGold deferred share units conversion, Number of shares       1,130        
NovaGold deferred share units conversion, Ascribed value       $ 3        
Services settled by common shares, Number of shares 54,706 66,511 64,368 40,816 63,533 7,793 185,585  
Services settled by common shares, Ascribed value $ 30 $ 30 $ 30 $ 20 $ 35 $ 4 $ 90  
Joint venture equity contribution (note 3(a)), Number of shares     143,507     143,505 143,507  
Joint venture equity contribution (note 3(a)), Ascribed value $ 112           $ 112  
Ending balance, Number of shares outstanding 160,567,514           160,567,514 155,925,990
Beginning balance, Number of shares     155,925,990       155,925,990  
Ending balance, Ascribed value $ 190,200           $ 190,200 $ 187,886
Beginning balance, Ascribed value     $ 187,886       $ 187,886  
Contributed surplus.                
Class of Stock [Line Items]                
NovaGold deferred share units conversion, Ascribed value       $ (3)        
v3.24.3
Share capital - Assumptions used in the pricing model (Details)
9 Months Ended
Aug. 31, 2024
$ / shares
Share-Based Payment Arrangement [Abstract]  
Risk-free interest rates 3.84%
Exercise price $ 0.59
Expected life 3 years
Expected volatility 65.50%
Expected dividends
v3.24.3
Share capital - Stock options plans and changes (Details)
9 Months Ended
Aug. 31, 2024
$ / shares
shares
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Balance - end of period, number of options 14,316,900
Balance - end of period, weighted average exercise price | $ / shares $ 1.78
Stock options  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Balance - beginning of the year, number of options 12,649,400
Balance - beginning of the year, weighted average exercise price | $ / shares $ 2.15
Number of options, Granted 2,775,000
Weighted average exercise price, Granted | $ / shares $ 0.59
Number of options, Exercised 0
Number of options, Expired (1,107,500)
Weighted average exercise price, Expired | $ / shares $ 2.96
Balance - end of period, number of options 14,316,900
Balance - end of period, weighted average exercise price | $ / shares $ 1.78
v3.24.3
Share capital - Stock options outstanding (Details)
9 Months Ended
Aug. 31, 2024
$ / shares
shares
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Number of outstanding options | shares 14,316,900
Weighted average years to expiry 2 years 2 months 4 days
Weighted average exercise price options outstanding $ 1.78
Number of exercisable options | shares 11,783,561
Weighted average exercise price exercisable $ 2.03
Number of unvested options | shares 2,533,339
$0.59 to $1.00  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Exercise price lower range limit $ 0.59
Exercise price upper range limit $ 1.00
Number of outstanding options | shares 5,955,000
Weighted average years to expiry 3 years 8 months 23 days
Weighted average exercise price options outstanding $ 0.69
Number of exercisable options | shares 3,421,661
Weighted average exercise price exercisable $ 0.72
Number of unvested options | shares 2,533,339
$2.01 to $3.00  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Exercise price lower range limit $ 2.01
Exercise price upper range limit $ 3.00
Number of outstanding options | shares 7,016,900
Weighted average years to expiry 1 year 2 months 15 days
Weighted average exercise price options outstanding $ 2.47
Number of exercisable options | shares 7,016,900
Weighted average exercise price exercisable $ 2.47
Number of unvested options | shares 0
$3.01 to $3.41  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Exercise price lower range limit $ 3.01
Exercise price upper range limit $ 3.02
Number of outstanding options | shares 1,345,000
Weighted average years to expiry 3 months 25 days
Weighted average exercise price options outstanding $ 3.02
Number of exercisable options | shares 1,345,000
Weighted average exercise price exercisable $ 3.02
Number of unvested options | shares 0
v3.24.3
Share capital - Unit plans and changes (Details)
9 Months Ended
Aug. 31, 2024
shares
Restricted Stock Units (RSUs) [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Balance - beginning of the period 1,610,638
Granted 5,705,718
Vested/Converted (4,498,017)
Balance - end of the period 2,818,339
DSUs  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Balance - beginning of the period 2,428,701
Granted 551,676
Balance - end of the period 2,980,377
v3.24.3
Financial instruments - Narrative (Details)
3 Months Ended 9 Months Ended
Aug. 31, 2024
USD ($)
Aug. 31, 2024
USD ($)
Sep. 03, 2024
USD ($)
Aug. 31, 2024
CAD ($)
Nov. 30, 2023
USD ($)
Accounts receivable $ 8,000 $ 8,000     $ 33,000
Balance 25,000,000 $ 25,000,000      
Change $ 250,000        
Servicing Assets and Servicing Liabilities at Fair Value, Assumptions Used to Estimate Fair Value, Weighted Average Life 1 year        
Subsequent Event [Member]          
Accrued salaries     $ 153,000    
10% change in the US-Canadian exchange rate          
Cash       $ 11,000  
Accounts receivable       11,000  
Accounts payable       $ 34,000  
Change in foreign exchange rate 10.00% 10.00%   10.00%  
Foreign exchange loss   $ 1,000      
1% change in interest rates          
Change in interest rate 1.00% 1.00%   1.00%  
v3.24.3
Financial instruments - Contractually obligated cash flow requirements (Details)
$ in Thousands
Aug. 31, 2024
USD ($)
Total $ 586
Contractual Obligation, to be Paid, Remainder of Fiscal Year 441
1 - 2 Years 102
2 - 5 Years 43
Thereafter 0
Accounts payable and accrued liabilities  
Total 391
Contractual Obligation, to be Paid, Remainder of Fiscal Year 391
1 - 2 Years 0
2 - 5 Years 0
Thereafter 0
Office lease  
Total 195
Contractual Obligation, to be Paid, Remainder of Fiscal Year 50
1 - 2 Years 102
2 - 5 Years 43
Thereafter $ 0
v3.24.3
Subsequent event (Details) - USD ($)
9 Months Ended
Sep. 03, 2024
Aug. 31, 2024
Nov. 30, 2023
Subsequent Event [Line Items]      
Cash and cash equivalents   $ 25,738,000 $ 2,590,000
Restricted Stock Units (RSUs) [Member]      
Subsequent Event [Line Items]      
Granted units   5,705,718  
Subsequent Event [Member] | Restricted Stock Units (RSUs) [Member] | Senior management      
Subsequent Event [Line Items]      
Granted (in shares) 298,263    
Stock issued in lieu of salaries $ 153,000    
Subsequent Event [Member] | DSUs. | Director [Member]      
Subsequent Event [Line Items]      
Granted (in shares) 153,035    
Stock issued in lieu of director fees $ 78,250    

Trilogy Metals (AMEX:TMQ)
Historical Stock Chart
From Oct 2024 to Nov 2024 Click Here for more Trilogy Metals Charts.
Trilogy Metals (AMEX:TMQ)
Historical Stock Chart
From Nov 2023 to Nov 2024 Click Here for more Trilogy Metals Charts.